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Abstract	  	  
Mycobacteria	  smegmatis	  is	  an	  abundant	  soil	  and	  water	  inhabitant	  with	  which	  
humans	  are	  continuously	  in	  contact.	  Despite	  the	  fact	  that	  it	  is	  typically	  
considered	  non-­‐pathogenic,	  a	  few	  rare	  cases	  of	  M.	  smegmatis-­‐caused	  
infections	  have	  been	  reported	  and	  it	  has	  been	  shown	  that	  M.	  smegmatis	  is	  able	  
to	  modulate	  inflammatory	  responses	  in	  macrophages.	  Neutrophils	  are	  the	  
innate	  immune	  system’s	  first	  line	  of	  centralized	  defense	  against	  invading	  
microbes,	  especially	  the	  frequently	  encountered	  M.	  smegmatis.	  However,	  very	  
little	  information	  is	  known	  of	  the	  mechanism	  by	  which	  neutrophils	  eliminate	  
environmental	  bacteria.	  In	  this	  study,	  the	  hypothesis	  that	  M.	  smegmatis	  
regulates	  neutrophil	  functional	  responses,	  and	  that	  some	  of	  these	  
manipulations	  may	  involve	  M.	  smegmatis’	  virulence-­‐associated	  glycolipid,	  
PILAM	  was	  tested	  by	  specifically	  examining	  its	  effect	  on	  two	  of	  the	  major	  
neutrophil	  responses:	  cytokine	  release	  and	  bacterial	  killing	  through	  
degranulation	  and	  respiratory	  burst	  activity.	  Our	  data	  showed	  that	  this	  
bacterium	  promotes	  inflammation,	  tissue	  damage	  and	  manipulates	  the	  Th1	  
response	  by	  controlling	  IL-­‐12.	  In	  addition,	  PILAM	  seems	  to	  be	  involved	  in	  the	  
neutrophil	  responses	  of	  intracellular	  ROS,	  gelatinase	  granule	  exocytosis	  and	  
IL-­‐12	  release.	  	  Consequently,	  the	  interaction	  between	  human	  neutrophils	  and	  
M.	  smegmatis	  appears	  to	  be	  much	  more	  intricate	  than	  formerly	  described.	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   Humans	  are	  in	  daily,	  continuous	  contact	  with	  an	  innumerable	  amount	  of	  bacteria;	  
however,	  the	  majority	  of	  bacterial	  exposure	  does	  not	  lead	  to	  illness	  or	  disease.	  The	  first	  
barriers	  against	  most	  microorganisms	  are	  the	  epithelial	  surfaces	  of	  the	  body,	  but	  if	  these	  
surfaces	  are	  breached,	  the	  immune	  system	  will	  become	  involved	  to	  control	  or	  eliminate	  any	  
foreign	  entities.	  The	  immune	  system	  is	  split	  into	  innate	  and	  adaptive	  immunity,	  each	  
encompassing	  different	  but	  overlapping	  functions	  (1).	  Innate	  immunity	  is	  characterized	  by	  
its	  built-­‐in,	  non-­‐specific	  and	  immediate	  responses	  for	  recognition	  and	  destruction	  of	  any	  
foreign	  microorganism.	  On	  the	  other	  hand,	  the	  adaptive	  immunity	  presents	  an	  acquired,	  
specific,	  memory-­‐dependent	  protection	  against	  microorganisms	  to	  prevent	  reinfection	  by	  
the	  same	  pathogens.	  The	  functional	  variability	  between	  the	  wings	  of	  the	  immune	  system	  is	  
mediated	  through	  the	  cells	  associated	  with	  each	  wing;	  monocytes,	  macrophages,	  dendritic	  
cells	  and	  polymorphonuclear	  cells	  make	  up	  the	  innate	  immune	  cell	  response	  whereas	  B	  
and	  T	  cell	  lymphocytes	  manage	  the	  adaptive	  immune	  response	  (1).	  	  
Neutrophils	  
Polymorphonuclear	  cells	  (PMNs),	  which	  are	  commonly	  known	  as	  neutrophils,	  are	  
indispensible	  in	  the	  protection	  against	  infectious	  agents	  that	  have	  penetrated	  the	  physical	  
barriers	  of	  the	  human	  body	  and	  play	  a	  large	  role	  in	  the	  development	  of	  innate	  and	  acute	  
inflammatory	  responses.	  After	  being	  produced	  in	  great	  quantities	  in	  the	  bone	  marrow	  (2),	  
these	  leukocytes	  are	  released	  into	  the	  blood	  stream	  in	  their	  naïve	  state	  where	  they	  scour	  
the	  body	  for	  signs	  of	  infection	  and	  inflammation	  (3).	  	  The	  power	  of	  neutrophil	  involvement	  
in	  host	  responses	  is	  most	  dramatically	  emphasized	  in	  individuals	  with	  neutrophil	  genetic	  
disorders	  or	  low	  peripheral	  neutrophil	  counts.	  Without	  the	  critical	  quantity	  of	  neutrophils	  
necessary	  to	  block	  microbial	  advances,	  infections	  develop	  with	  increased	  frequency,	  
severity,	  and	  overall	  host	  mortality	  (4).	  	  
	  The	  recruitment	  of	  neutrophils	  to	  sites	  of	  infection	  begins	  when	  local	  macrophages	  
produce	  signals	  called	  cytokines	  and	  chemokines	  in	  response	  to	  microbial	  intruders.	  These	  
compounds	  activate	  the	  local	  endothelial	  cells	  of	  the	  vascular	  walls,	  which	  will	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subsequently	  express	  selectins	  and	  integrins	  on	  their	  membranes	  and	  capture	  and	  activate	  
patrolling	  neutrophils	  (2).	  The	  activated	  neutrophils	  can	  then	  migrate	  into	  the	  infected	  
tissue	  by	  either	  penetrating	  an	  individual	  endothelial	  cell	  or	  wedging	  between	  two	  
endothelial	  cells.	  In	  the	  infected	  area,	  the	  products	  generated	  by	  live	  bacteria	  or	  other	  
proteins	  produced	  by	  local	  immune	  cells	  act	  as	  chemotactic	  signals	  that	  will	  guide	  the	  
neutrophils	  to	  the	  intruders	  (2).	  Once	  inside	  the	  area	  of	  infection,	  neutrophils	  can	  perform	  
an	  array	  of	  sophisticated	  functions	  to	  control	  microbial	  pathogenesis.	  	  The	  two	  functions	  of	  
most	  relevance	  to	  this	  project,	  which	  will	  be	  described	  in	  detail,	  are	  neutrophils’	  ability	  to	  
destroy	  microbes	  through	  either	  intracellular	  or	  extracellular	  means	  and	  neutrophils’	  
capacity	  to	  produce	  and	  release	  cytokines	  for	  recruitment	  and	  activation	  of	  other	  immune	  
cells.	  	  
The	  best	  established	  role	  of	  neutrophils	  is	  that	  of	  professional	  phagocytic	  cells,	  
whose	  microbial	  killing	  capabilities	  involve	  both	  oxygen	  dependent	  and	  independent	  
mechanisms.	  	  Intracellular	  killing	  by	  neutrophils	  first	  involves	  the	  uptake	  of	  bacteria	  into	  a	  
vacuole	  by	  a	  process	  called	  phagocytosis.	  The	  phagocytic	  event	  triggers	  activation	  of	  the	  
NADPH	  oxidase	  multi-­‐enzymatic	  complex,	  resulting	  in	  oxygen	  consumption	  with	  the	  
generation	  of	  reactive	  oxygen	  species	  (ROS)	  called	  the	  respiratory	  burst.	  	  Depending	  on	  the	  
stimuli,	  the	  newly	  formed	  reactive	  oxygen	  species	  can	  be	  unloaded	  into	  the	  phagosomal	  
vacuole	  or	  released	  from	  the	  neutrophil.	  	  In	  addition,	  characteristic	  neutrophil	  granules	  
fuse	  with	  the	  phagocytic	  vacuole,	  releasing	  their	  microbicidal	  protein	  content,	  and	  
contributing	  to	  the	  maturation	  of	  the	  phagosome	  (5).	  Since	  these	  granules	  are	  filled	  with	  
antimicrobial	  and	  tissue-­‐digesting	  compounds,	  the	  combination	  of	  the	  reactive	  oxidative	  
species	  and	  the	  digestive	  granule	  proteins	  creates	  a	  deadly	  cocktail	  (6).	  	  This	  intricate	  
process	  begins	  with	  either	  direct	  recognition	  of	  the	  trespassing	  microbe	  by	  pattern	  
recognition	  receptors	  (TLRs)	  and/or	  by	  phagocytic	  receptors	  such	  as	  FcγRs	  and	  
complement	  receptors	  that	  are	  present	  on	  the	  neutrophil	  plasma	  membrane	  (7).	  Microbial	  
opsonization	  is	  the	  process	  by	  which	  the	  complement	  system	  tags	  pathogens	  with	  serum	  
components	  C1-­‐C9.	  These	  serum	  components	  that	  opsonize	  bacteria	  are	  analogous	  to	  
antibodies	  in	  the	  adaptive	  immune	  system	  because	  they	  mediate	  pathogen	  recognition	  and	  
phagocytosis,	  but	  in	  a	  non-­‐specific	  way.	  Studies	  have	  confirmed	  that	  human	  neutrophils	  
	   6	  
can	  recognize	  and	  internalize	  both	  opsonized	  and	  non-­‐opsonized	  bacteria,	  although	  
bacteria	  uptake	  by	  neutrophils	  is	  more	  efficient	  with	  opsonized	  bacteria	  (8).	  
Neutrophil	  granules	  play	  a	  fundamental	  role	  in	  neutrophil	  microbial	  killing.	  	  The	  
abundant	  neutrophil	  granules	  can	  be	  divided	  into	  four	  subtypes	  and	  make	  neutrophils	  part	  
of	  the	  exclusive,	  3-­‐member	  granulocyte	  family	  (6).	  The	  four	  granule	  subtypes	  are	  formed	  at	  
different	  stages	  of	  neutrophil	  maturation	  within	  the	  bone	  marrow	  and	  display	  great	  
heterogeneity	  in	  their	  content	  as	  well	  as	  their	  readiness	  for	  exocytosis	  after	  stimulation.	  As	  
the	  nature	  of	  the	  granule	  content	  becomes	  more	  destructive,	  the	  degranulation	  becomes	  
increasingly	  difficult	  and	  highly	  controlled	  (9).	  This	  specificity	  of	  release	  gives	  a	  glimpse	  of	  
the	  sophistication	  of	  neutrophils,	  given	  that	  the	  uncontrolled	  liberation	  of	  ROS	  and	  granule	  
content	  would	  harm	  host	  tissues	  as	  an	  undesirable	  side	  effect.	  	  
Some	  of	  the	  granule	  content	  is	  found	  in	  several	  granule	  types;	  however,	  each	  
granule	  subtype	  will	  have	  exclusive	  granule	  content	  and	  plasma	  membrane	  specific	  
markers,	  which	  allows	  for	  quantification	  of	  each	  granule’s	  activity.	  The	  most	  readily	  
released	  granules,	  the	  secretory	  vesicles,	  are	  the	  last	  ones	  formed	  during	  neutrophil	  
maturation.	  Although	  these	  vesicles	  only	  contain	  harmless	  plasma	  proteins	  within,	  the	  
vesicle	  membrane	  is	  abundant	  in	  receptors.	  Because	  of	  their	  readiness	  in	  mobilization,	  it	  is	  
believed	  that	  they	  are	  released	  when	  the	  neutrophil	  first	  encounters	  the	  endothelium	  that	  
has	  become	  activated	  by	  chemokines	  and	  cytokines	  that	  indicate	  a	  bacterial	  presence	  (10).	  
With	  the	  fusion	  of	  granules	  into	  the	  neutrophil’s	  plasma	  membrane,	  all	  the	  receptors	  
present	  on	  the	  vesicle	  membrane	  are	  incorporated	  into	  the	  cell’s	  plasma	  membrane,	  
transforming	  the	  neutrophils	  from	  a	  passive	  cell	  to	  a	  highly	  sensitive,	  primed	  one	  (11).	  	  
Gelatinase	  or	  tertiary	  granules	  are	  the	  third	  granules	  formed	  during	  neutrophil	  maturation,	  
and	  require	  a	  stronger	  stimulus	  to	  be	  mobilized	  compared	  to	  secretory	  vesicles.	  Gelatinase	  
granules	  contain	  a	  high	  number	  of	  matrix	  metalloproteases	  (MMPs)	  such	  as	  MMP-­‐9	  
(gelatinase)	  and	  MMP-­‐8	  (collagenase).	  These	  enzymes	  have	  protease	  activity	  and	  allow	  
neutrophil	  migration	  into	  tissues	  from	  the	  endothelial	  lining	  via	  the	  breakdown	  of	  the	  basal	  
membrane	  (2).	  	  
Specific	  or	  secondary	  granules	  are	  the	  second	  produced	  and	  require	  a	  stronger	  
stimulus	  to	  be	  mobilized	  compared	  to	  gelatinase	  granules.	  Containing	  of	  high	  
concentrations	  of	  lactoferrin,	  the	  specific	  granules	  are	  associated	  with	  bacteriostatic	  and	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bactericidal	  functions.	  Lactoferrin	  is	  a	  protein	  that	  impedes	  bacterial	  proliferation	  by	  
sequestering	  iron	  from	  the	  surrounding	  environment	  and	  disrupting	  the	  outer	  bacterial	  
membrane	  through	  the	  dispersion	  of	  components	  such	  as	  lipopolysaccharide	  (LPS)	  (12).	  
Azurophil	  or	  primary	  granules	  are	  the	  first	  formed	  during	  neutrophil	  maturation	  and	  are	  
the	  most	  difficult	  to	  mobilize,	  but	  also	  house	  some	  of	  the	  deadliest	  protein	  contents:	  
myeloperoxidase	  and	  defensins	  (9,	  10).	  The	  azurophil	  granules’	  myeloperoxidase	  kills	  and	  
digests	  bacteria	  by	  targeting	  their	  membrane	  transport	  proteins,	  adenosine	  triphosphate	  
(ATP)	  generating	  systems,	  and	  DNA	  replication	  origins	  (13).	  	  In	  addition,	  myeloperoxidase	  
catalyzes	  the	  production	  of	  additional	  strong	  microbicidal	  compounds,	  like	  hypochlorous	  
acid	  (HOCl).	  HOCl	  is	  made	  when	  the	  superoxide	  from	  the	  respiratory	  burst	  undergo	  
dismutation	  into	  hydrogen	  peroxide	  that	  is	  combined	  with	  chloride	  anions	  in	  the	  
phagosomal	  vacuole.	  Furthermore,	  azurophil	  granules	  also	  contain	  defensins,	  which	  can	  
permeabilize	  the	  bacterial	  membrane	  (14).	  	  
	   Neutrophils	  were	  originally	  only	  believed	  to	  be	  a	  part	  of	  the	  innate	  immune	  system,	  
modulating	  host	  responses	  against	  pathogens	  in	  acute	  inflammation.	  However,	  in	  the	  last	  
15	  years,	  it	  has	  been	  shown	  that	  neutrophils	  spontaneously	  or	  under	  appropriate	  
stimulation	  can	  synthesize	  and	  release	  cytokines	  and	  chemokines,	  which	  are	  involved	  in	  
directing	  incoming	  leukocytes	  and	  the	  regulation	  of	  the	  immune	  response	  (15,	  16).	  
Interleukin	  12	  (IL-­‐12)	  is	  a	  key	  proinflammatory	  cytokine	  in	  host	  defense	  against	  
mycobacterial	  infections,	  and	  it	  has	  been	  reported	  that	  neutrophils	  can	  release	  IL-­‐12	  (17).	  
In	  the	  early	  stages,	  great	  numbers	  of	  neutrophils	  accumulate	  at	  the	  infection	  site,	  allowing	  
these	  innate	  immune	  cells	  to	  contribute	  to	  large	  amounts	  of	  IL-­‐12	  (7,	  18).	  	  The	  presence	  of	  
IL-­‐12	  and	  interferon	  gamma	  (IFN-­‐γ),	  another	  cytokine	  that	  is	  produced	  by	  natural	  killer	  
cells,	  result	  in	  enhanced	  macrophage	  ability	  to	  kill	  bacteria,	  leading	  to	  the	  differentiation	  of	  
helper	  T	  cells	  into	  TH1	  cells	  (19).	  The	  development	  of	  a	  TH1	  response	  is	  of	  great	  importance	  
because	  it	  is	  associated	  with	  protective	  host	  immunity	  and	  the	  elimination	  of	  intracellular	  
infectious	  agents	  (18,	  20).	  Thus,	  neutrophil	  production	  and	  release	  of	  IL-­‐12	  during	  a	  
bacterial	  infection	  is	  useful	  in	  the	  study	  of	  the	  organism’s	  fate.	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Mycobacterium	  smegmatis	  
	   Mycobacterium	  smegmatis	  (M.	  smegmatis)	  is	  a	  rod-­‐shaped,	  Gram-­‐positive	  and	  acid-­‐
fast	  saprophyte	  member	  of	  the	  rapidly	  growing	  division	  of	  the	  mycobacteria	  family.	  First	  
isolated	  in	  1884	  by	  Lustgarten,	  M.	  smegmatis	  is	  in	  the	  non-­‐obligate	  pathogens’	  sector	  of	  the	  
environmental	  mycobacteria,	  and	  typically	  inhabit	  soils,	  natural	  waters,	  and	  municipal	  
waters	  (21).	  Therefore,	  due	  to	  the	  ecological	  niches	  of	  M.	  smegmatis,	  humans	  are	  commonly	  
exposed	  to	  it,	  even	  though	  this	  interaction	  rarely	  leads	  to	  illness	  or	  disease	  (22).	  
Nevertheless,	  despite	  typically	  being	  considered	  non-­‐pathogenic,	  M.	  smegmatis	  retains	  the	  
capacity	  to	  manipulate	  macrophage	  responses.	  It	  has	  the	  ability	  to	  survive	  and	  multiply	  
within	  macrophages	  and	  delays	  the	  phagosomal	  acidification	  that	  accompanies	  the	  
dumping	  of	  microbicidal	  agents	  (23,	  24).	  Rare,	  but	  critical,	  cases	  of	  M.	  smegmatis-­‐caused	  
acute	  and	  chronic	  soft	  tissue,	  wound,	  or	  pleuropulmonary	  infections	  have	  been	  reported	  in	  
both	  healthy	  and	  immunocompromised	  individuals	  (25).	  	  
Further	  emphasizing	  the	  presence	  of	  an	  established	  immune	  response	  against	  the	  
frequently	  encountered	  M.	  smegmatis	  is	  the	  incidence	  of	  false	  positive	  Mantoux	  tuberculin	  
tests.	  The	  skin	  test	  specifically	  assesses	  the	  adaptive	  immunity’s	  T	  cell-­‐mediated	  responses	  
to	  the	  tuberculin	  protein,	  which	  is	  injected	  intradermally	  and	  is	  meant	  to	  detect	  previous	  
exposure	  to	  Mycobacteria	  tuberculosis	  (21,	  26).	  Interestingly,	  there	  is	  a	  high	  prevalence	  of	  
false	  positive	  Mantoux	  tests	  due	  to	  individuals	  acquiring	  increased	  sensitivity	  and	  cross	  
reactivity	  to	  the	  tuberculin	  protein	  from	  the	  recurrent	  exposure	  to	  environmental	  
mycobacteria	  (26,	  27).	  This	  reiterates	  the	  ability	  of	  environmental	  mycobacteria	  to	  
modulate	  the	  immune	  system	  even	  though	  it	  is	  considered	  non-­‐pathogenic.	  	  
Phosphoinositol	  Lipoarabinomannan	  
One	  of	  the	  primary	  ways	  immune	  cells	  interact	  with	  and	  detect	  invading	  bacteria	  is	  
through	  the	  recognition	  of	  bacterial	  surface	  lipoglycans	  through	  pattern	  recognition	  
receptors	  on	  immune	  cells.	  Recognition	  through	  specific	  receptors	  will	  activate	  different	  
pathways	  and	  influence	  the	  outcome	  of	  not	  only	  the	  immune	  response	  but	  the	  fate	  of	  the	  
bacteria	  as	  well.	  On	  the	  cell	  envelope,	  all	  mycobacterial	  species	  contain	  a	  variation	  of	  the	  
glycolipid	  Lipoarabinomannan	  (LAM),	  which	  is	  typically	  associated	  with	  virulence.	  The	  cell	  
envelope	  of	  M.	  smegmatis	  is	  studded	  with	  phosphoinositol-­‐capped	  lipoarabinomannan	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(PILAM),	  which	  has	  been	  shown	  to	  play	  a	  role	  in	  modulating	  host	  macrophage	  responses	  
during	  infection	  and	  resembles	  the	  structure	  of	  lipopolysaccharide	  (LPS)	  in	  Gram	  negative	  
bacteria	  (28).	  Specifically	  in	  macrophages,	  PILAM	  is	  a	  potent	  inducer	  of	  IL-­‐12	  secretion,	  
programmed	  cell	  death,	  and	  tumor	  necrosis	  factor	  alpha	  (TNF-­‐α),	  a	  cytokine	  that	  is	  
released	  in	  the	  presence	  of	  bacteria	  and	  enhances	  phagocytosis	  (17,	  29).	  Thus,	  observing	  
the	  interactions	  between	  PILAM	  and	  human	  neutrophils	  could	  offer	  further,	  more	  specific	  
insight	  as	  to	  how	  M.	  smegmatis	  may	  be	  involved	  in	  the	  innate	  system	  regulation.	  	  
Compared	  to	  other	  immune	  cells,	  neutrophils	  are	  a	  relatively	  understudied	  cell	  type,	  
as	  is	  judged	  by	  the	  academic	  literature	  available.	  This	  is	  partly	  due	  to	  the	  inherent	  
properties	  of	  human	  neutrophil	  research,	  such	  as	  their	  easy	  activation,	  short	  life	  span	  and	  
inability	  for	  preservation.	  Furthermore,	  studying	  neutrophils	  require	  daily	  isolation	  from	  
donor	  blood,	  which	  adds	  variability,	  because	  the	  neutrophil	  cell	  lines	  available	  lack	  some	  of	  
the	  granule	  components	  that	  are	  present	  in	  donor-­‐isolated	  cells.	  Furthermore,	  there	  is	  
minimal	  information	  available	  regarding	  neutrophil	  interactions	  with	  environmental	  
mycobacteria	  and	  the	  effect	  of	  the	  PI	  cap	  of	  LAM	  on	  neutrophils	  is	  unknown.	  M.	  smegmatis	  
has	  been	  proposed	  as	  a	  model	  organism	  for	  the	  study	  of	  Mycobacteria	  tuberculosis,	  the	  
causative	  agent	  of	  tuberculosis.	  M.	  smegmatis	  has	  a	  much	  shorter	  generation	  time,	  lower	  
biosafety	  level	  requirements,	  many	  conserved	  virulence	  genes,	  and	  ease	  in	  genetic	  
manipulation	  because	  of	  the	  shorter	  doubling	  time,	  making	  this	  avirulent	  microbe	  
particularly	  appealing	  (30).	  	  The	  purpose	  of	  the	  present	  study	  was	  to	  make	  a	  
comprehensive	  and	  comparison	  of	  the	  interaction	  between	  human	  primary	  neutrophils	  
and	  viable	  M.	  smegmatis	  cells	  compared	  to	  stimulation	  with	  PILAM	  alone.	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Materials	  &	  methods	  
	  
o Buffers	  and	  Media:	  	  
o Krebs+	  buffer:	  NaCl,	  KCl,	  Dextrose,	  NaPhosphate	  (Monobasic	  and	  dibasic)	  
CaCl2	  and	  MgSO4	  dissolved	  in	  deionized	  water	  at	  pH=7.4	  and	  kept	  at	  4°C	  in	  
depyrogenated	  bottles.	  
o RPMI:	  RPMI-­‐1640	  (Life	  Technology),	  0.1%	  l-­‐Glutamine,	  10%	  Heat	  inactivated	  
Fetal	  Bovine	  Serum.	  	  
o MOPS	  +	  MgCl:	  (Molecular	  Sigma	  Biology,	  M8899)	  After	  dissolving	  MOPS	  
powder,	  1%	  MgCl	  was	  added	  and	  the	  solution	  was	  adjusted	  to	  a	  pH	  of	  7.2	  
o Incubations:	  Unless	  otherwise	  noted,	  all	  incubations	  were	  performed	  in	  a	  37°C	  
water	  bath	  with	  shaking.	  	  
Neutrophil	  isolation	  	  
Human	  neutrophils	  were	  isolated	  daily	  from	  healthy	  donors	  using	  Plasma-­‐Percoll	  
Gradients	  as	  previously	  described	  (31).	  	  Trypan blue exclusion indicated >97 % viability for 
the enriched cell populations, which contained > 95% neutrophils as judged by microscopic 
examination. Human donor recruitment, blood draws and the use of the material were performed 
according to guidelines approved by the Institutional Review Board of the University of 
Louisville. For	  all	  experimental	  conditions	  performed	  in	  this	  study,	  a	  concentration	  of	  
neutrophils	  of	  4×10!	  cells/mL	  was	  used	  unless	  otherwise	  noted.	  	  
Mycobacterium	  smegmatis	  	  
• Bacteria	  Growth	  
Non-­‐labeled	  and	  green	  fluorescent	  protein	  (GFP,	  from	  a	  plasmid)-­‐expressing	  
bacteria	  were	  grown	  to	  mid-­‐log,	  exponential	  phase	  in	  7H9	  medium	  with	  10%	  ADC	  
(Albumindextrose	  complex	  supplement,	  10	  g	  bovine	  serum	  albumin	  fraction	  V	  (BSA),	  15	  g	  
D-­‐glucose	  and	  1.6	  g	  NaCl	  in	  200mL	  of	  water)	  at	  37	  °C	  on	  a	  rotating	  drum.	  	  Before	  use,	  the	  
bacteria	  were	  subjected	  to	  a	  light	  centrifugation	  (300	  rpm	  for	  3	  min)	  and	  only	  the	  
supernatant	  used	  to	  avoid	  any	  large	  clumps	  of	  bacterial	  cells.	  The	  total	  bacterial	  
concentration	  was	  determined	  using	  a	  spectrophotometer	  where	  O.D.600=	  1	  is	  equivalent	  to	  
6  ×  10!	  bacteria.	  All	  experiments	  with	  M.	  smegmatis	  were	  performed	  at	  a	  multiplicity	  of	  
infection	  (MOI)	  of	  6:1.	  
• Bacteria	  Opsonization	  
M.	  smegmatis	  was	  first	  centrifuged	  at	  6000	  g	  for	  5	  min	  at	  room	  temperature,	  the	  
supernatant	  discarded	  and	  the	  bacteria	  pellet	  was	  resuspended	  in	  a	  1:1	  Krebs+	  buffer	  and	  
human	  serum	  (Complement	  technology,	  NHS)	  mixture.	  	  The	  cells	  were	  incubated	  without	  
agitation	  for	  at	  least	  20	  minutes	  at	  room	  temperature,	  followed	  by	  pelleting	  and	  
resuspension	  with	  Krebs+	  two	  times.	  All	  bacterial	  conditions	  were	  performed	  with	  
opsonized	  or	  non-­‐opsonized	  M.	  smegmatis.	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• Heat-­‐killed	  Bacteria	  
Opsonized	  M.	  smegmatis	  was	  placed	  in	  a	  90°	  C	  water	  bath	  for	  2	  hours	  followed	  by	  a	  
thorough	  mixing	  through	  a	  21gauge	  needle	  syringe	  to	  avoid	  any	  bacterial	  clumps.	  The	  
bacteria	  suspension	  was	  separated	  into	  aliquots	  with	  a	  cell	  density	  of	  2.4  ×  10!cells/mL	  
and	  stored	  at	  -­‐80	  °C.	  	  
• UV-­‐killed	  Bacteria	  
Ten	  microliter	  drops	  of	  non-­‐opsonized	  M.	  smegmatis	  solution	  (108	  cells/mL)	  were	  
pipetted	  in	  rows	  on	  a	  sterile	  petri	  dish.	  The	  petri	  dish	  was	  shielded	  with	  aluminum	  foil	  and	  
placed	  six	  inches	  away	  from	  a	  UV	  lamp.	  The	  aluminum	  foil	  shield	  was	  removed	  so	  that	  each	  
row	  was	  uncovered	  at	  specific	  times,	  and	  thus	  exposed	  each	  row	  to	  an	  increasing	  UV	  
dosage.	  The	  drops	  of	  bacteria	  from	  each	  row	  were	  plated	  and	  their	  viability	  was	  assessed	  
after	  2	  days	  by	  counting	  colony-­‐forming	  units	  (CFU).	  It	  was	  determined	  that	  3	  min	  of	  UV	  
exposure	  rendered	  the	  bacteria	  unviable.	  All	  subsequent	  experiments	  requiring	  UV-­‐killed	  
bacteria	  were	  completed	  with	  M.	  smegmatis	  exposed	  to	  UV	  light	  for	  3	  min.	  	  
	  
Phosphoinositol	  Lipoarabinomannan	  (PILAM)	  
PILAM	  was	  purchased	  from	  Invivogen	  (catalog	  #tlrl-­‐lams,	  version	  #06C31-­‐MT)	  in	  
powder	  form.	  The	  PILAM	  powder	  was	  dissolved	  in	  sterile	  endotoxin-­‐free	  deionized	  water	  
to	  a	  concentration	  of	  20	  μg/mL	  and	  stored	  at	  -­‐20	  °C.	  For	  all	  experiments	  involving	  PILAM,	  
concentrations	  of	  either	  20	  μg/mL	  or	  40	  μg/mL	  were	  used.	  	  
Neutrophil	  degranulation/exocytosis	  
• Measurement	  of	  azurophil	  granules,	  specific	  granules,	  and	  secretory	  vesicles	  	  
Quantitative	  analysis	  of	  azurophil	  granule,	  specific	  granule,	  and	  secretory	  vesicle	  
exocytosis	  was	  determined	  by	  measuring	  the	  increase	  in	  the	  presence	  of	  fluorescently	  
tagged	  granule	  markers	  (CD63,	  CD66b,	  and	  CD35	  respectively)	  in	  the	  cell	  plasma	  
membrane	  using	  flow	  cytometry	  (FACS Calibur®).	  Neutrophils	  were	  unstimulated,	  or	  
stimulated	  with	  formyl-­‐methionyl-­‐leucyl-­‐phenylalanine	  (fMLF	  (Sigma-Aldrich,	  300	  nM,	  for	  
5	  min)	  after	  the	  presence	  or	  absence	  of	  PILAM	  (20	  µg/ml,	  or	  40	  µg/ml)	  for	  30	  minutes,	  or	  
in	  the	  presence	  or	  absence	  of	  opsonized	  or	  non-­‐opsonized	  M.	  smegmatis	  for	  15,	  30,	  or	  60	  
minutes.	  	  After	  stimulation,	  cells	  were	  incubated	  on	  ice	  in	  the	  dark	  for	  45	  minutes	  with	  
fluorochrome-­‐conjugated	  antibodies	  specific	  to	  each	  granule	  marker	  fluoresecein	  
isothiocyanate	  (FITC)-­‐conjugated	  anti-­‐CD63	  (azurophil	  granule,	  Ancell	  215-­‐040),	  FITC-­‐
conjugated	  anti-­‐CD66b	  (specific	  granule,	  Biolegend),	  and	  pycoerythrin	  (PE)-­‐conjugated	  
anti-­‐CD35	  (secretory	  vesicle,	  Biolegend	  333406).	  	  Following	  antibody	  incubation,	  cells	  
were	  washed	  with	  FTA	  buffer	  (BD	  211248)	  +	  0.1%	  sodium	  azide	  (Sigma)	  and	  fixed	  with	  
1%	  paraformaldehyde	  (EMD	  PX0055-­‐3)	  in	  FTA.	  
Formylated	  peptides,	  like	  fMLF,	  are	  derived	  from	  bacterial	  protein	  degradation	  and	  
are	  a	  potent	  neutrophil	  chemoattractant	  and	  activator.	  	  Experimentally,	  fMLF	  alone	  was	  
used	  as	  a	  positive	  control	  to	  measure	  neutrophil	  degranulation,	  as	  well	  as	  when	  combined	  
with	  other	  stimuli	  to	  mimic	  the	  conditions	  of	  a	  multi-­‐bacterial	  attack	  or	  chronic	  infection	  
conditions.	  Only	  20%	  of	  azurophil	  granules	  are	  mobilized	  upon	  neutrophil	  activation,	  and	  
in	  vitro,	  it	  requires	  disruption	  of	  the	  actin	  cytoskeleton	  followed	  by	  fMLF	  stimulation.	  	  For	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the	  experimental	  conditions	  where	  azurophil	  granule	  exocytosis	  was	  measured,	  cells	  were	  
pre-­‐treated	  with	  the	  actin-­‐disrupting	  drug,	  latrunculin	  A	  (1	  μM,	  30min,	  Sigma	  L5163).	  	  
• Measurement	  of	  degranulation	  of	  gelatinase	  granules	  using	  Enzyme-­‐linked	  
immunosorbent	  Assay	  (ELISA)	  
	   Degranulation	  of	  gelatinase	  granules	  was	  determined	  by	  measuring	  the	  release	  of	  
gelatinase	  (matrix	  metalloprotease	  MMP-­‐9)	  from	  unstimulated,	  or	  stimulated	  cells	  via	  
enzyme-­‐linked	  immunosorbent	  assays	  (ELISA,	  R&D	  systems,	  DMP900).	  	  The	  same	  
experimental	  conditions	  described	  above	  for	  the	  other	  granule	  subtypes	  were	  performed.	  
Following	  stimulation	  cells	  were	  centrifuged	  at	  6000g	  for	  30	  seconds	  at	  room	  temperature,	  
the	  supernatants	  were	  carefully	  removed	  from	  the	  cells	  into	  100	  μL	  aliquot	  along	  with	  1%	  
phosphatase	  and	  1%	  protease	  inhibitors	  into	  sterile	  microcentrifuge	  tubes,	  and	  stored	  at	  -­‐
80	  °C	  until	  use.	  	  
Respiratory	  burst	  
• Phagocytosis-­‐stimulated	  respiratory	  burst	  	  	  
For	  experiments	  using	  PILAM,	  neutrophils	  (2x106	  cells/mL)	  were	  unstimulated,	  or	  
stimulated	  with	  opsonized	  Staphylococcus	  aureus	  (Pansorbin	  cells,	  Calbiochem,	  507861,	  
opsonized	  with	  plasma,	  MOI	  6:1)	  for	  10	  minutes,	  in	  the	  presence	  or	  absence	  of	  PILAM	  (20	  
µg/ml,	  or	  40	  µg/ml,	  30	  min),	  or	  in	  the	  presence	  or	  absence	  of	  either	  opsonized	  or	  non-­‐
opsonized	  M.	  smegmatis	  	  (MOI	  6:1,	  10	  min).	  	  	  Respiratory	  burst	  triggered	  by	  phagocytosis	  
was	  detected	  by	  measuring	  ROS	  production	  with	  50	  µM	  2′,	  7′-­‐dichlorofluorescein	  diacetate	  
(DCF,	  Molecular	  Probes).	  	  DCF	  is	  a	  cell	  permeable	  non-­‐fluorescent	  probe	  that	  becomes	  the	  
fluorescent	  2’,7’-­‐dichlorofluorescin	  upon	  oxidation	  by	  the	  respiratory	  burst	  in	  neutrophils.	  	  
Phagocytosis-­‐stimulated	  respiratory	  burst	  response	  was	  quantified	  by	  flow	  cytometry.	  
• ROS	  production	  in	  the	  phagosome	  
	  
Neutrophils	  (2x106	  cells/mL)	  were	  attached	  to	  plasma-­‐coated	  coverslips	  and	  
challenged	  with	  GFP-­‐tagged	  M.	  smegmatis	  	  (opsonized	  or	  non-­‐opsonized,	  MOI	  6:1)	  in	  RPMI	  
media	  containing	  Nitro	  Blue	  tetrazolium	  (NBT,	  Sigma	  N6639)	  for	  one	  hour.	  Coverslips	  were	  
fixed	  with	  methanol	  and	  then	  mounted	  onto	  a	  microscope	  slide	  and	  sealed	  with	  clear	  nail	  
polish.	  NBT	  is	  a	  cytochemical	  stain	  that	  is	  reduced	  in	  the	  presence	  of	  oxidative	  species	  and	  
will	  form	  deep	  blue	  deposits	  that	  outline	  intracytoplasmic	  deposits	  of	  ROS.	  	  Localization	  of	  
the	  bacterium	  within	  neutrophil	  phagosomes	  was	  determined	  by	  confocal	  microscopy.	  
Simultaneously,	  imaging	  of	  areas	  with	  NBT	  reduction	  was	  obtained	  using	  light	  microscopy.	  
The	  confocal	  microscopy	  images	  distinguished	  if	  the	  areas	  of	  ROS	  production	  were	  the	  
same	  as	  the	  location	  of	  M.	  smegmatis	  in	  phagosomes.	  Unstimulated	  neutrophils	  were	  
utilized	  as	  negative	  control,	  and	  cells	  challenged	  with	  opsonized	  S.	  aureus	  or	  opsonized	  
zymosan	  (Life	  Technologies),	  a	  particle	  that	  is	  usually	  found	  on	  the	  cell	  wall	  of	  yeast,	  were	  
used	  as	  positive	  controls.	  	  
• Extracellular	  respiratory	  burst	  activity	  	  
A	  time	  course	  was	  performed	  to	  determine	  if	  viable	  M.	  smegmatis	  	  (opsonized,	  or	  
non-­‐opsonized,	  MOI	  6:1)	  would	  induce	  superoxide	  release.	  For	  those	  experimental	  
	   13	  
conditions,	  cells	  were	  unstimulated,	  or	  stimulated	  with	  fMFL	  (300	  nM,	  5	  min),	  or	  opsonized	  
S.	  aureus	  (MOI	  6:1),	  or	  opsonized	  or	  non-­‐opsonized	  M.	  smegmatis	  	  (MOI	  6:1),	  for	  5,	  15,	  or	  
30	  min.	  	  After	  each	  treatment,	  the	  cells	  were	  centrifuged	  and	  the	  supernatants	  collected,	  
and	  the	  concentration	  of	  extracellular	  superoxide	  was	  calculated	  spectrophotometrically	  
(550	  nm)	  by	  measuring	  the	  color	  change	  that	  results	  from	  the	  reduction	  of	  
Ferricytochrome	  C	  (FCC,	  10	  mg/mL,	  Sigma	  C7752).	  	  	  
Bacterial	  viability	  	  
To	  determine	  if	  neutrophils	  were	  able	  to	  kill	  M.	  smegmatis,	  a	  bacterial	  viability	  kit	  
(BacLight,	  Invitrogen	  Molecular	  probes	  L7012)	  was	  used	  taking	  advantage	  of	  the	  
permeability	  properties	  of	  2	  nucleic	  acid	  dyes.	  	  One	  of	  the	  dyes,	  SYTO	  9,	  is	  membrane	  
permeable	  and	  will	  stain	  both	  live	  and	  dead	  bacteria	  cells.	  The	  other	  dye,	  propidium	  iodide	  
(PI),	  is	  a	  non-­‐permeable	  dye,	  which	  will	  only	  enter	  and	  stain	  bacterial	  cells	  that	  have	  
compromised	  membranes	  and	  are	  classified	  as	  nonviable.	  	  When	  both	  dyes	  are	  combined,	  
the	  PI	  will	  reduce	  the	  SYTO9	  and	  dead	  bacteria	  will	  stain	  red	  only,	  while	  viable	  bacteria	  will	  
stain	  with	  a	  green	  color.	  This	  assay	  was	  modified	  specifically	  for	  M.	  smegmatis	  from	  
Johnson	  and	  Criss	  (32).	  	  
Neutrophils	  (2x106	  cells/mL)	  were	  attached	  to	  plasma-­‐coated	  coverslips	  and	  
challenged	  with	  opsonized	  M.	  smegmatis	  for	  30	  minutes	  in	  24-­‐well	  plates.	  The	  cells	  were	  
treated	  with	  the	  combination	  of	  dyes,	  30	  μM	  PI	  and	  2	  μM	  SYTO	  9	  mixed	  into	  MOPS	  buffer	  
with	  0.1%	  saponin	  from	  quillaja	  bark	  (Sigma	  Life	  science	  S4521-­‐25G).	  	  Following	  the	  
incubation	  time,	  the	  cells	  were	  stained	  in	  the	  dark	  for	  15	  minute	  at	  room	  temperature.	  Two	  
washes	  were	  performed	  with	  MOPS	  buffer	  to	  remove	  excess	  dye	  staining.	  The	  coverslips	  
were	  removed	  from	  the	  plate	  wells,	  placed	  on	  microscope	  slides,	  sealed	  with	  clear	  nail	  
polish	  and	  analyzed	  with	  confocal	  microscopy.	  	  The	  controls	  for	  the	  assay	  were	  live	  and	  
heat-­‐killed	  bacteria	  alone.	  	  	  
IL-­‐12	  Cytokine	  release	  
Supernatants	  and	  cell	  lysates	  were	  collected	  from	  neutrophils	  that	  were	  
unstimulated,	  or	  stimulated	  with	  interferon	  gamma	  (IFN-­‐γ,	  50	  ng/mL	  (BD	  Pharmingen)	  
and	  LPS	  (1	  μg/mL)	  in	  the	  presence	  or	  absence	  of	  LAM	  (20	  μg/mL)	  or	  M.	  smegmatis	  	  	  
(opsonized	  or	  non-­‐opsonized)	  in	  RPMI	  media	  overnight.	  	  IFN-­‐γ	  and	  LPS	  stimulation	  was	  
used	  as	  a	  positive	  control	  that	  will	  trigger	  the	  release	  of	  IL-­‐12	  by	  human	  neutrophils.	  	  
All	  experimental	  manipulations	  were	  performed	  using	  sterile	  technique	  in	  a	  tissue	  
culture	  hood.	  	  After	  24	  hours	  of	  stimulation,	  cells	  were	  centrifuged,	  their	  supernatant	  
removed	  and	  aliquoted	  with	  1%	  protease	  and	  phosphatase	  inhibitors	  each.	  The	  cell	  pellet	  
was	  further	  processed	  by	  disrupting	  the	  cells	  at	  4°C	  for	  30	  minutes	  on	  a	  rotator	  with	  lysis	  
buffer	  (AKT	  buffer	  +	  1%	  protease	  inhibitor,	  1%	  phosphatase	  inhibitor,	  1%	  Na3VO4,	  1%	  
AEBsf).	  	  Subsequently,	  the	  lysed	  cells	  were	  centrifuged	  and	  the	  lysate	  supernatant	  collected	  
and	  stored	  at	  -­‐80°C.	  IL-­‐12	  levels	  were	  measured	  using	  an	  ELISA	  kit	  (BioLegend	  431704).	  	  
Statistical	  Analysis	  
Statistical	  differences	  among	  experimental	  conditions,	  and/or	  time	  points,	  were	  
analyzed	  by	  ANOVA	  and	  the	  Tukey	  multiple-­‐comparison	  (GraphPad	  Software,	  San	  Diego,	  
CA).	  Differences	  were	  considered	  significant	  at	  the	  level	  P	  <	  0.05.
Results	  and	  Discussion	  
	  
	   The	  immune	  system	  is	  very	  effective	  at	  eliminating	  M.	  smegmatis,	  which	  is	  evidenced	  by	  the	  rarity	  
of	  M.	  smegmatis-­‐derived	  infections.	  However,	  the	  exact	  mechanism	  for	  this	  killing	  is	  unknown,	  and	  even	  
less	  is	  known	  about	  the	  mechanism	  of	  pathogenesis	  during	  those	  rare	  cases	  where	  M.	  smegmatis	  is	  able	  
to	  cause	  acute	  and	  chronic	  infections.	  As	  the	  first	  responders	  of	  innate	  immunity,	  neutrophils	  are	  a	  key	  
player	  in	  the	  clearing	  of	  microbe	  intruders,	  making	  them	  relevant	  to	  studies	  between	  the	  human	  immune	  
system	  and	  environmental	  mycobacteria.	  	  	  
DEGRANULATION/EXOCYTOSIS	  
	  
Following	  stimulation	  by	  M.	  smegmatis	  or	  PILAM,	  the	  degranulation	  of	  the	  four	  granule	  subtypes	  
was	  analyzed	  either	  by	  using	  flow	  cytometry	  or	  ELISA.	  	  
Neither	  PILAM	  nor	  M.	  smegmatis	  have	  an	  effect	  on	  secretory	  vesicle	  exocytosis	  
	   	  
Fig.	  1:	  Exocytosis	  of	  Secretory	  vesicles.	  Human	  neutrophils	  (4x106	  cells/ml)	  were	  unstimulated	  (Basal),	  or	  stimulated	  with	  formyl-­‐methionyl-­‐leucyl-­‐
phenylalanine	  (fMLF,	  300	  nM,	  5	  min),	  in	  the	  presence	  or	  absence	  of	  opsonized	  or	  non-­‐opsonized	  M.	  smegmatis	  at	  an	  MOI	  of	  6:1	  (A)	  or	  presence	  or	  absence	  of	  
increasing	  concentrations	  of	  PILAM	  (B).	  Exocytosis	  of	  secretory	  vesicles	  (CD35	  plasma	  membrane	  expression)	  was	  measured	  by	  flow	  cytometry.	  Data	  are	  
expressed	  as	  mean	  ±	  SEM	  of	  the	  mean	  channel	  of	  fluorescence	  (mcf).	  
	  
Embedded	  on	  the	  secretory	  vesicles	  are	  many	  receptors	  that	  are	  incorporated	  into	  the	  cell’s	  
membrane	  after	  degranulation.	  These	  receptors	  transform	  naïve	  neutrophils	  into	  extremely	  sensitive	  
cells,	  primed	  for	  detecting	  any	  microbe	  or	  signal	  from	  the	  environment	  with	  greater	  responsiveness.	  
However,	  after	  exposure	  to	  only	  opsonized	  or	  non-­‐opsonized	  M.	  smegmatis,	  neutrophils	  had	  similar	  
levels	  of	  the	  CD35	  marker,	  which	  is	  characteristic	  of	  the	  secretory	  vesicles,	  when	  compared	  to	  the	  
untreated	  neutrophils	  (Fig.	  1A).	  This	  indicates	  that	  M.	  smegmatis	  presence	  is	  not	  a	  source	  of	  neutrophil	  
membrane	  sensitization.	  Furthermore,	  it	  suggests	  that	  the	  mechanism	  of	  elimination	  for	  M.	  smegmatis	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does	  not	  require	  the	  recognition	  of	  the	  bacterium	  by	  the	  receptors	  that	  are	  contained	  in	  the	  secretory	  
vesicles.	  	  
Incubation	  for	  15	  min	  with	  opsonized	  M.	  smegmatis	  followed	  by	  subsequent	  5	  min	  fMLF	  
stimulation	  resulted	  in	  an	  enhanced	  exocytosis	  of	  secretory	  vesicles	  compared	  to	  fMLF	  alone	  (Fig.	  1	  A).	  
These	  results	  indicate	  that	  opsonized	  M.	  smegmatis	  was	  able	  to	  prime	  the	  neutrophil	  response.	  	  As	  time	  
progressed,	  there	  is	  a	  decreasing	  trend	  in	  the	  exocytosis	  of	  these	  granules,	  but	  this	  could	  be	  due	  to	  the	  
induction	  of	  endocytosis	  rather	  than	  inhibition	  of	  exocytosis.	  If	  bacteria	  are	  engulfed,	  there	  will	  be	  a	  
decrease	  in	  the	  receptors	  available	  for	  fMLF	  stimulation,	  thus	  explaining	  the	  decrease	  in	  plasma	  
membrane	  expression.	  	  	  
Similarly	  to	  the	  response	  seen	  with	  the	  whole	  bacterium,	  the	  presence	  of	  increasing	  
concentrations	  of	  PILAM	  is	  unable	  to	  effect	  a	  change	  in	  secretory	  vesicle	  exocytosis	  compared	  to	  
untreated	  cells	  or	  fMLF-­‐treated	  cells	  (Fig.	  1B).	  Since	  the	  in	  vitro	  fMLF-­‐stimulation	  of	  neutrophils	  mimics	  
the	  activated	  cell	  phenotype	  induced	  by	  bacteria,	  the	  stable	  secretory	  vesicle	  release	  suggests	  that	  the	  
presence	  of	  PILAM	  alone	  will	  neither	  enhance	  nor	  dampen	  the	  reactivity	  of	  neutrophils	  against	  M.	  
smegmatis.	  	  
Non-­‐opsonized	  M.	  smegmatis	  significantly	  induced	  gelatinase	  granule	  release.	  	  
	  
Fig.	  2:	  Exocytosis	  of	  Gelatinase	  granules.	  Human	  neutrophils	  (4x106	  cells/ml)	  were	  unstimulated	  (Basal),	  or	  stimulated	  with	  formyl-­‐methionyl-­‐
leucyl-­‐phenylalanine	  (fMLF,	  300	  nM,	  5	  min),	  in	  the	  presence	  or	  absence	  of	  opsonized	  or	  non-­‐opsonized	  M.	  smegmatis	  at	  an	  MOI	  of	  6:1	  (A)	  or	  presence	  or	  
absence	  of	  increasing	  concentrations	  of	  PILAM	  (B).	  Exocytosis	  of	  gelatinase	  granules	  (MMP-­‐9	  release)	  was	  measured	  by	  ELISA.	  Data	  are	  expressed	  as	  the	  
mean	  ±	  SEM	  of	  ng/ml	  of	  gelatinase	  release;	  *p<0.05	  compared	  to	  control.	  	  
	  
Gelatinase	  granules	  are	  often	  exocytosed	  by	  neutrophils	  for	  tissue	  migration	  after	  
transendothelial	  movement	  because	  the	  enzymes	  within	  these	  granulesprotease.	  Our	  data	  showed	  that	  
60	  min	  of	  bacterial	  challenge	  	  (opsonized	  or	  non-­‐opsonized)	  resulted	  in	  a	  similar	  release	  of	  MMP-­‐9	  as	  
fMLF-­‐stimulation,	  which	  was	  used	  as	  a	  positive	  control	  for	  this	  assay	  (Fig.	  2A).	  In	  addition,	  a	  significant	  
increase	  of	  MMP-­‐9	  release	  was	  observed	  when	  neutrophils	  were	  pre-­‐treated	  with	  non-­‐opsonized	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bacteria	  for	  60	  min	  followed	  by	  fMLF-­‐stimulation	  (Fig.	  2A).	  	  Similar	  results	  were	  observed	  when	  
neutrophils	  were	  challenged	  with	  just	  the	  glycolipid	  PILAM	  (Fig.	  2B).	  	  PILAM	  alone	  was	  able	  to	  induce	  
gelatinase	  granule	  exocytosis	  and	  was	  able	  to	  enhance	  the	  MMP-­‐9	  release	  after	  fMLF-­‐stimulation	  (Fig.	  
2B).	  This	  finding	  describes	  a	  defensive	  host	  mechanism	  because	  the	  additional	  gelatinase	  release	  makes	  
movements	  throughout	  the	  tissue	  easier	  and	  thus	  the	  infection	  can	  be	  cleared	  much	  faster.	  However,	  
significant	  exocytosis	  of	  these	  granules	  has	  been	  linked	  with	  host	  tissue	  damage,	  and	  gives	  some	  insight	  
into	  the	  role	  that	  M.	  smegmatis	  may	  play	  in	  its	  rare	  chronic	  infections.	  The	  presence	  of	  this	  environmental	  
bacterium	  induces	  neutrophils	  to	  secrete	  extracellular	  matrix-­‐degrading	  proteins	  that	  could	  worsen	  a	  
developing	  or	  established	  infection	  and	  prevent	  resolution.	  	  
Furthermore,	  the	  difference	  seen	  between	  the	  opsonized	  or	  non-­‐opsonized	  bacterium	  could	  be	  
explained	  by	  the	  fact	  that	  opsonization	  aids	  in	  recognition	  and	  phagocytosis,	  meaning	  that	  neutrophils	  
will	  not	  have	  to	  travel	  as	  much	  within	  tissue	  to	  find	  and	  engulf	  the	  intruders.	  If	  the	  bacteria	  are	  non-­‐
opsonized,	  neutrophils	  could	  have	  greater	  difficulties	  locating	  and	  internalizing	  these	  microbes,	  meaning	  
that	  the	  signals	  of	  bacterial	  presence	  would	  continue	  to	  induce	  inflammation,	  further	  stressing	  the	  
neutrophils.	  In	  addition,	  some	  of	  the	  proteases	  that	  are	  released	  from	  gelatinase	  granules	  are	  involved	  in	  
shedding	  of	  IL-­‐8,	  L-­‐selectin,	  and	  CD35.	  This	  cell	  surface	  reorganization	  may	  further	  activate	  other	  
receptors.	  Together,	  the	  combined	  release	  of	  the	  gelatinase	  would	  result	  in	  detrimental	  host	  tissue	  
damage.	  	  	  
Neither	  M.	  smegmatis	  nor	  PILAM	  induced	  specific	  granule	  exocytosis	  
	  
Fig.	  3:	  Exocytosis	  of	  Specific	  Granules.	  Human	  neutrophils	  (4x106	  cells/ml)	  were	  unstimulated	  (Basal),	  or	  stimulated	  with	  formyl-­‐methionyl-­‐leucyl-­‐
phenylalanine	  (fMLF,	  300	  nM,	  5	  min),	  in	  the	  presence	  or	  absence	  of	  opsonized	  or	  non-­‐opsonized	  M.	  smegmatis	  at	  an	  MOI	  of	  6:1	  (A)	  or	  presence	  or	  absence	  of	  
increasing	  concentrations	  of	  PILAM	  (B).	  Exocytosis	  of	  specific	  granules	  (CD66b	  plasma	  membrane	  expression)	  was	  measured	  by	  flow	  cytometry.	  Data	  are	  
expressed	  as	  mean	  ±	  SEM	  of	  the	  mean	  channel	  of	  fluorescence	  (mcf).	  
	  
Unlike	  the	  secretory	  vesicles	  and	  the	  gelatinase	  granules,	  specific	  granules	  contain	  high	  
concentration	  of	  microbicidal	  proteins.	  Characterized	  by	  the	  presence	  of	  lactoferrin	  and	  other	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bacteriostatic	  or	  bactericidal	  compounds,	  the	  mobilization	  of	  this	  granule	  is	  highly	  controlled.	  Therefore,	  
it	  was	  not	  surprising	  that	  neither	  opsonized	  bacteria,	  non-­‐opsonized	  bacteria,	  nor	  PILAM	  were	  able	  to	  
induce	  the	  extracellular	  release	  of	  these	  granule	  components	  compared	  to	  untreated	  cells	  (Fig.	  3A	  and	  
3B).	  Moreover,	  exposure	  of	  neutrophils	  to	  PILAM	  or	  M.	  smegmatis	  did	  not	  further	  incite	  the	  expression	  of	  
CD66b	  on	  neutrophil	  membranes	  in	  fMLF-­‐stimulated	  cells	  (Fig.	  3A	  and	  3B).	  This	  suggests	  that	  neither	  the	  
whole	  organism	  nor	  PILAM	  specifically,	  is	  able	  to	  give	  sufficient	  signaling	  for	  lactoferrin	  release	  into	  the	  
extracellular	  matrix	  when	  acting	  alone	  or	  as	  a	  cohort	  with	  another	  microbe.	  The	  mobilization	  of	  these	  
granules	  may	  be	  reserved	  for	  much	  more	  pathogenic	  organisms	  due	  to	  the	  potential	  host	  tissue	  
destruction	  from	  exocytosis.	  Interestingly,	  this	  finding	  confirms	  previous	  data	  showing	  that	  during	  
neutrophil	  exposure	  to	  M.	  smegmatis	  at	  an	  MOI	  of	  50,	  specific	  granules	  exocytosis	  is	  not	  enhanced	  by	  M.	  
smegmatis	  whether	  it	  is	  opsonized	  or	  non-­‐opsonized	  (8).	  The	  current	  experiments	  were	  performed	  at	  an	  
MOI	  of	  6,	  suggesting	  that	  neutrophil	  specific	  granule	  responses	  remain	  unchanged	  even	  when	  they	  face	  a	  
steep	  increase	  in	  microbes	  to	  combat.	  	  
Non-­‐opsonized	  and	  UV-­‐killed	  M.	  smegmatis	  significantly	  induced	  fMLF-­‐stimulated	  azurophil	  granule	  








Fig.	  4:	  Exocytosis	  of	  Azurophilic	  Granules.	  Human	  
neutrophils	  (4x106	  cells/ml)	  were	  unstimulated	  (Basal),	  or	  
stimulated	  with	  formyl-­‐methionyl-­‐leucyl-­‐phenylalanine	  (fMLF,	  
300	  nM,	  5	  min),	  in	  the	  presence	  or	  absence	  of	  opsonized,	  non-­‐
opsonized	  (A)	  M.	  smegmatis,	  increasing	  concentrations	  of	  PILAM	  
(B),	  or	  UV-­‐killed	  M.	  smegmatis	  (C)	  at	  an	  MOI	  of	  6:1.	  Exocytosis	  of	  
azurophil	  granules	  (CD63	  plasma	  membrane	  expression)	  was	  
measured	  by	  flow	  cytometry.	  Data	  are	  expressed	  as	  mean	  ±	  SEM	  of	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The	  deadliest	  granule	  contents,	  myeloperoxidase	  and	  defensins,	  are	  within	  the	  azurophil	  granules.	  
Due	  to	  their	  effectiveness	  as	  sterilants,	  the	  release	  of	  this	  granule’s	  content	  into	  the	  extracellular	  matrix	  is	  
the	  most	  challenging.	  Nevertheless,	  despite	  an	  inability	  to	  mobilize	  the	  granules	  independently	  as	  
previously	  seen	  in	  other	  studies	  (8),	  pre-­‐incubation	  of	  neutrophils	  with	  non-­‐opsonized	  M.	  smegmatis	  was	  
able	  to	  increase	  the	  fMLF-­‐stimulated	  plasma	  membrane	  expression	  of	  CD63	  (Fig	  4A).	  This	  finding	  is	  
particularly	  supportive	  of	  the	  role	  of	  M.	  smegmatis	  in	  chronic	  illnesses	  because	  the	  increased	  release	  of	  
these	  granules	  in	  an	  ongoing	  infection	  would	  be	  a	  major	  source	  of	  host	  tissue	  damage	  and	  inflammation.	  	  
The	  data	  also	  shows	  that	  from	  15	  to	  60	  minutes	  post-­‐infection,	  the	  amount	  of	  azurophil	  exocytosis	  does	  
not	  increase,	  suggesting	  that	  the	  primary	  granule	  response	  will	  reach	  its	  maximum	  exocytosis	  almost	  
immediately	  after	  encountering	  M.	  smegmatis.	  	  This	  robust	  unloading	  of	  myeloperoxidase	  shortly	  after	  
the	  initial	  encounter	  offers	  a	  mechanism	  for	  the	  cases	  of	  acute	  inflammation	  with	  M.	  smegmatis.	  Because	  
the	  added	  presence	  of	  M.	  smegmatis	  induces	  the	  amplified	  azurophil	  degranulation,	  it	  could	  also	  
inadvertently	  be	  acting	  as	  a	  catalyst	  to	  spur	  neutrophils	  to	  eliminate	  the	  bacteria	  and	  clear	  the	  infection	  
sooner	  than	  if	  M.	  smegmatis	  would	  not	  have	  been	  present.	  	  
UV-­‐exposure	  affects	  the	  mycobacterial	  DNA,	  making	  it	  unviable,	  and	  thus	  preventing	  the	  bacteria	  
from	  creating	  and	  secreting	  any	  compounds	  in	  a	  stress-­‐state	  after	  interacting	  with	  neutrophils.	  When	  the	  
outer	  membrane	  components	  remain	  intact,	  experiments	  with	  the	  UV-­‐killed	  organism	  give	  insight	  into	  
the	  relevant	  question	  of	  whether	  or	  not	  M.	  smegmatis	  actively	  regulates	  neutrophil’s	  azurophil	  
exocytosis.	  Similar	  to	  the	  viable	  M.	  smegmatis,	  testing	  with	  the	  UV-­‐killed	  microbe	  also	  displayed	  an	  
augmented	  azurophil	  degranulation	  in	  fMLF-­‐activated	  neutrophils	  (Fig.	  4C).	  This	  outcome	  is	  significant	  
because	  it	  indicates	  that	  the	  viable	  bacterium	  does	  not	  actively	  control	  this	  reaction	  and	  that	  signaling	  
pathways	  triggered	  by	  receptor	  recognition	  or	  phagocytosis	  are	  involved	  in	  the	  regulation	  of	  
degranulation.	  	  
Since	  a	  membrane	  component	  is	  responsible	  for	  the	  observed	  effect	  on	  primary	  granule	  
exocytosis,	  treatment	  of	  neutrophils	  with	  PILAM	  was	  a	  critical	  facet	  of	  this	  work.	  Pre-­‐treatment	  of	  
neutrophils	  with	  PILAM	  decreased	  CD63	  plasma	  membrane	  expression	  in	  fMLF-­‐treated	  neutrophils,	  but	  
PILAM	  treatment	  alone	  had	  no	  effect	  (Fig.	  4B).	  	  Although	  the	  decrease	  on	  CD63	  plasma	  membrane	  is	  less	  
pronounced	  and	  did	  not	  reach	  statistical	  significance,	  similar	  results	  were	  observed	  when	  neutrophils	  
were	  pre-­‐incubated	  for	  60	  min	  with	  opsonized	  M.	  smegmatis	  (Fig.	  4A).	  In	  other,	  more	  pathogenic	  
mycobacterial	  species,	  the	  LAM	  glycolipid	  is	  associated	  with	  virulence,	  so	  in	  the	  context	  of	  the	  
mycobacterial	  genus,	  it	  becomes	  relevant	  that	  PILAM	  decreased	  the	  azurophil	  degranulation	  because	  it	  
could	  provide	  the	  bacterium	  with	  a	  mechanism	  for	  evading	  neutrophil	  killing.	  	  In	  addition,	  the	  difference	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observed	  in	  the	  regulation	  of	  granule	  exocytosis	  between	  challenging	  neutrophils	  with	  opsonized	  vs	  non-­‐
opsonized	  bacteria	  emphasizes	  the	  importance	  of	  the	  opsonization	  process	  in	  determining	  the	  fate	  of	  the	  
bacterium	  and	  the	  degree	  of	  neutrophil	  activation.	  	  Additionally,	  in	  the	  rare	  cases	  of	  infection	  with	  M.	  
smegmatis,	  the	  decreased	  azurophil	  granule	  exocytosis	  would	  also	  protect	  the	  other	  bacteria	  in	  the	  
environment,	  prolonging	  the	  infection.	  When	  comparing	  the	  result	  of	  treatment	  with	  PILAM	  alone	  and	  
with	  UV-­‐killed	  M.	  smegmatis,	  it	  becomes	  clear	  that	  other	  components	  of	  the	  membrane	  could	  have	  a	  
greater	  effect	  on	  the	  fate	  of	  M.	  smegmatis	  since	  the	  opposite	  effects	  on	  exocytosis	  were	  observed.	  	  
Respiratory	  Burst	  Response	  
	  
	   The	  most	  potent	  microbicidal	  mechanisms	  employed	  by	  neutrophils	  is	  the	  intracellular	  and	  
extracellular	  release	  of	  ROS.	  This	  is	  induced	  by	  activation	  of	  the	  respiratory	  burst	  against	  M.	  smegmatis,	  
and	  is	  a	  critical	  component	  in	  the	  study	  of	  the	  cell-­‐bacteria	  interaction.	  Due	  to	  the	  rarity	  of	  M.	  smegmatis	  
infection,	  an	  increased	  ROS	  production	  intracellularly	  or	  extracellularly	  was	  expected.	  For	  comparison,	  
the	  experiments	  were	  performed	  alongside	  opsonized	  and	  non-­‐opsonized	  S.	  aureus,	  another	  Gram-­‐
positive	  microbe	  that	  is	  known	  to	  induce	  a	  robust	  oxidative	  burst	  in	  neutrophils.	  	  
Opsonized	  M.	  smegmatis	  and	  PILAM	  significantly	  induce	  a	  time-­‐dependent	  increase	  in	  intracellular	  oxidants	  
production	  	  
	  
Fig.	  5.	  Intracellular	  oxidants	  production.	  	  Human	  neutrophils	  (2x106	  cells/ml)	  were	  exposed	  to	  2’-­‐7’-­‐dichlorofluorescin	  
diacetate	  (DCF)	  in	  the	  presence	  of	  human	  serum	  opsonized	  or	  non-­‐opsonized	  M.	  smegmatis	  or	  heat-­‐killed,	  opsonized	  S.	  aureus	  
at	  an	  MOI	  of	  6:1	  (A)	  or	  increasing	  concentrations	  of	  PILAM	  (20	  μg/mL	  or	  40	  μg/mL)	  alone	  or	  followed	  by	  stimulation	  with	  S.	  
aureus	  (B).	  Intracellular	  oxidants	  production	  was	  determined	  by	  flow	  cytometry	  measuring	  the	  oxidation	  of	  DCF.	  Data	  are	  
expressed	  as	  mean	  ±	  SEM	  of	  the	  mean	  channel	  of	  fluorescence	  (mcf);	  *	  p<0.05	  compared	  to	  non-­‐opsonized	  S.	  aureus,	  **p<0.05	  
compared	  to	  non-­‐opsonized	  M.	  smegmatis	  (A).	  After	  exposure	  to	  PILAM	  (B),	  *	  P	  <	  0.05	  compared	  to	  basal	  control,	  **	  P	  <	  0.05	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Both	  non-­‐opsonized	  Gram-­‐positive	  bacteria	  induced	  a	  moderate	  intracellular	  oxidative	  response,	  
with	  minimal	  increase	  in	  ROS	  production	  between	  the	  10	  and	  30-­‐minute	  time	  points	  (Fig.	  5A).	  Regardless	  
of	  the	  time	  point,	  however,	  the	  opsonization	  of	  either	  bacterium	  substantially	  increased	  the	  ROS	  
response	  when	  compared	  to	  their	  non-­‐opsonized	  counterparts	  at	  the	  same	  time	  point.	  This	  emphasizes	  
the	  significance	  that	  the	  type	  of	  microbial	  recognition	  defines	  the	  fate	  of	  the	  microbe	  because	  
complement	  recognition	  by	  the	  complement	  receptor	  led	  to	  a	  phagocytic	  event	  that	  culminated	  in	  greater	  
ROS	  production	  than	  the	  internalization	  of	  non-­‐opsonic	  bacteria.	  Moreover,	  after	  30	  min	  challenge	  with	  
opsonized	  M.	  smegmatis,	  an	  even	  greater	  oxidative	  response	  was	  seen	  when	  juxtaposed	  against	  
opsonized	  M.	  smegmatis	  after	  10	  minutes	  and	  opsonized	  S.	  aureus	  after	  30	  minutes.	  Therefore,	  in	  a	  time	  
dependent	  manner,	  opsonization	  of	  M.	  smegmatis	  significantly	  increased	  neutrophils’	  intracellular	  
oxidant	  production	  when	  compared	  to	  non-­‐opsonized	  M.	  smegmatis	  and	  opsonized	  S.	  aureus	  at	  30	  
minutes.	  Hence,	  these	  results	  indicate	  a	  greater	  efficiency	  of	  reactive	  oxidative	  species	  production	  when	  
the	  bacteria	  have	  been	  recognized	  and	  internalized	  with	  the	  help	  of	  complement.	  	  
PILAM	  also	  displayed	  some	  ability	  to	  induce	  intracellular	  oxidant	  production	  (Fig.	  5B).	  Increasing	  
PILAM	  concentrations	  significantly	  increased	  ROS	  response	  independently,	  which	  suggests	  that	  PILAM	  is	  
a	  potent	  inducer	  and	  a	  crucial	  factor	  in	  neutrophil	  oxidative	  burst	  activity	  against	  M.	  smegmatis.	  This	  
finding	  is	  even	  more	  noteworthy	  because	  previous	  studies	  have	  shown	  that	  mannose-­‐capped	  LAM	  
(ManLAM)	  and	  arabinose-­‐capped	  LAM	  (AraLAM)	  from	  other	  mycobacterial	  species	  do	  not	  significantly	  
activate	  the	  NADPH-­‐oxidase	  activity	  as	  measured	  by	  superoxide	  production	  (28).	  This	  difference	  could	  be	  
explained	  by	  different	  binding	  to	  the	  neutrophil	  receptor	  via	  the	  caps	  attached	  to	  the	  LAM	  structure.	  The	  
ability	  of	  PILAM	  to	  activate	  the	  NADPH	  response	  may	  provide	  one	  of	  the	  factors	  that	  make	  M.	  smegmatis	  
more	  susceptible	  to	  neutrophils	  when	  compared	  to	  its	  mycobacterial	  counterparts.	  Conflicting	  with	  this	  
finding,	  there	  is	  some	  evidence	  to	  suggest	  that	  human	  neutrophils	  kill	  invading	  mycobacteria	  by	  oxygen-­‐
independent	  methods	  only	  (33).	  A	  study	  from	  the	  University	  of	  Illinois	  at	  Chicago	  showed	  that	  
neutrophils	  from	  chronic	  granulomatous	  disease	  (CGD),	  which	  are	  unable	  to	  produce	  the	  oxygen	  radicals	  
of	  the	  respiratory	  burst,	  were	  equally	  efficient	  at	  killing	  mycobacteria	  as	  normal	  neutrophils	  (34).	  	  
	  Additionally,	  PILAM	  pre-­‐treatment	  before	  challenge	  with	  opsonized	  S.	  aureus	  significantly	  
increased	  neutrophil	  ROS	  production	  (Fig.	  5B).	  The	  expanded	  activation	  of	  intracellular	  ROS	  from	  PILAM	  
pre-­‐treated	  cells	  demonstrates	  that	  the	  mycobacterial	  glycolipid	  has	  a	  priming	  effect	  on	  neutrophils	  
unlike	  its	  LAM	  relatives,	  ManLAM	  and	  AraLAM	  (28).	  While	  in	  the	  primed	  state,	  there	  is	  no	  increase	  in	  the	  
NADPH	  oxidase	  activity	  initially;	  however,	  primed	  neutrophils’	  subsequent	  microbial	  interactions	  
provoke	  an	  amplified	  response	  when	  compared	  to	  non-­‐primed,	  activated	  cells.	  Previous	  work	  
determined	  that	  LPS-­‐primed	  neutrophils	  were	  able	  to	  kill	  80%	  of	  M.	  smegmatis	  after	  30	  min	  (33).	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Intracellular	  oxidants	  accumulate	  within	  phagosomes	  that	  contain	  M.	  smegmatis	  	  
A.	  Untreated	  	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  B.	  Opsonized	  Zymosan	  
	  	   	  	  	  	  	  	  	  	  	  	   	  
C.	  Heat-­‐killed,	  opsonized	  S.	  aureus	  
	  	  
D.	  Non-­‐opsonized	  M.	  smegmatis	  
	  	  	  	   	  	  	   	  
E.	  Opsonized	  M.	  smegmatis	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Fig.	  6.	  NBT	  staining	  of	  opsonized	  and	  non-­‐opsonized	  M.	  smegmatis.	  Neutrophils	  (2x106cell/ml)	  were	  either	  unstimulated	  
(UT)(A),	  stimulated	  with	  opsonized	  zymosan	  (MOI	  6:1)(B),	  heat-­‐killed	  opsonized	  S.	  aureus	  (MOI	  6:1)	  (C),	  non-­‐opsonized	  M.	  
smegmatis	  (MOI	  6:1)	  (D),	  or	  serum	  opsonized	  M.	  smegmatis	  (MOI	  6:1)(E)	  for	  60	  min	  in	  NBT	  media.	  Black	  arrows	  show	  
extracellular	  M.	  smegmatis;	  white	  arrows	  show	  NBT-­‐positive	  phagosomes.	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Another	  mycobacterial	  species,	  the	  highly	  pathogenic	  Mycobacteria	  tuberculosis,	  is	  known	  to	  
inhibit	  phagosome-­‐lysosome	  fusion	  through	  its	  LAM	  protein,	  ManLAM,	  in	  macrophages	  by	  inhibiting	  the	  
recruitment	  of	  lysosomal	  components	  (35).	  The	  increase	  in	  neutrophil’s	  intracellular	  ROS	  by	  opsonized	  
M.	  smegmatis	  and	  PILAM	  confirmed	  that	  intracellular	  oxidant	  production	  might	  be	  involved	  in	  the	  
degradation	  of	  the	  bacterium.	  To	  confirm	  the	  suspected	  ROS	  formation	  at	  the	  phagosome;	  neutrophils	  
were	  visualized	  with	  light	  microscopy	  post-­‐challenge	  with	  M.	  smegmatis	  in	  the	  presence	  of	  nitro-­‐blue	  
tetrazolium	  (NBT).	  The	  formation	  of	  navy	  blue	  deposits	  inside	  M.	  smegmatis-­‐containing	  phagosomes	  
would	  indicate	  oxidants	  were	  produced	  inside	  those	  phagosomal	  structures.	  The	  successful	  maturation	  of	  
the	  phagosome	  would	  offer	  a	  possible	  mechanism	  for	  killing	  M.	  smegmatis	  that	  differs	  from	  what	  has	  
been	  seen	  in	  macrophages	  when	  they	  are	  exposed	  to	  M.	  tuberculosis	  or	  ManLAM.	  	  
Untreated	  cells	  appeared	  mostly	  clear	  or	  a	  very	  light	  shade	  of	  blue,	  with	  very	  small	  and	  scarce	  
dark	  blue	  deposits	  (Fig.	  6	  A)	  whereas	  the	  positive	  controls,	  opsonized	  S.	  aureus	  and	  opsonized	  zymosan,	  
clearly	  exhibited	  small	  circular	  and	  large	  oval	  navy	  blue	  deposits	  on	  the	  phagosomal	  structures	  
respectively	  (Fig.	  6	  B,C).	  	  Even	  with	  uptake	  of	  either	  compound	  into	  the	  phagosome,	  the	  rest	  of	  the	  cell	  
retained	  a	  clear	  or	  light	  blue	  coloring	  indicative	  that	  the	  oxidation	  event	  was	  only	  taking	  place	  at	  the	  
compartment	  containing	  the	  infectious	  particle.	  When	  neutrophils	  were	  challenged	  with	  M.	  smegmatis,	  
the	  cells	  displayed	  rod-­‐shaped,	  dark	  blue	  NBT	  deposits	  within	  the	  cytoplasm	  that	  are	  indicative	  of	  ROS	  
production	  at	  a	  phagosome;	  however,	  when	  M.	  smegmatis	  was	  found	  outside	  of	  neutrophils,	  it	  also	  
stained	  dark	  blue	  (Fig.	  6	  D,	  E).	  	  The	  NBT	  staining	  of	  extracellular	  M.	  smegmatis	  raised	  doubts	  concerning	  
the	  intracellular	  respiratory	  burst	  at	  the	  phagosome.	  	  
Wild	  type	  M.	  smegmatis	  was	  substituted	  with	  GFP-­‐tagged	  M.	  smegmatis,	  and	  confocal	  microscopy	  
was	  used	  to	  acquire	  merged	  images	  that	  eliminated	  any	  doubt	  that	  there	  was	  co-­‐localization	  of	  the	  
fluorescently	  green	  bacteria	  and	  the	  dark	  blue	  deposits	  in	  the	  bright	  field	  microscopy	  channel	  (Fig.	  5).	  
Thus,	  the	  accumulation	  of	  intracellular	  oxidants	  at	  the	  phagosome	  was	  visually	  confirmed.	  These	  findings	  
not	  only	  further	  supporting	  the	  hypothesis	  that	  activation	  of	  the	  respiratory	  burst	  response	  is	  one	  of	  the	  
mechanisms	  used	  to	  eradicate	  M.	  smegmatis,	  but	  they	  also	  made	  a	  clear	  distinction	  that	  PILAM	  does	  not	  
behave	  in	  neutrophils	  like	  the	  virulent	  ManLAM	  does	  in	  macrophages.	  By	  not	  inhibiting	  the	  phagosome	  
maturation	  process,	  M.	  smegmatis	  is	  more	  susceptible	  to	  elimination	  and	  probably	  one	  of	  the	  reasons	  it	  is	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A.	  Untreated	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
B.	  Non-­‐opsonized	  M.	  smegmatis	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  C.	  Opsonized	  M.	  smegmatis	  
	  	  	  	  	  	  	  	  	  	  	  	   	  
Fig.7	  NBT	  staining	  of	  opsonized	  &	  non-­‐opsonized	  GFP-­‐tagged	  M.	  smegmatis.	  Neutrophils	  (2x106cell/ml)	  were	  unstimulated	  
(UT)(A),	  or	  stimulated	  with	  non-­‐opsonized	  M.	  smegmatis	  (MOI	  6:1)	  (B),	  or	  serum	  opsonized	  M.	  smegmatis	  (MOI	  6:1)(C)	  for	  60	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Opsonized	  M.	  smegmatis	  induced	  a	  potent	  extracellular	  oxidative	  burst	  	  
	  	  
Alternately,	  activation	  of	  the	  NADPH	  oxidase	  at	  the	  plasma	  membrane	  results	  in	  the	  release	  of	  
newly	  formed	  ROS	  to	  the	  extracellular	  space	  rather	  than	  into	  the	  phagosome.	  Similar	  to	  the	  results	  
obtained	  from	  the	  intracellular	  oxidative	  burst	  response,	  opsonized	  M.	  smegmatis	  induced	  a	  time-­‐
dependent,	  increasingly	  robust	  extracellular	  oxidant	  release	  when	  compared	  to	  opsonized	  M.	  smegmatis	  
at	  5	  and	  15	  minutes,	  and	  opsonized	  S.	  aureus	  at	  all	  time	  points	  (Fig.	  8).	  The	  superoxide	  ions	  produced	  
react	  quickly	  with	  other	  molecules,	  making	  this	  stimulant-­‐dependent	  process	  effective	  at	  killing	  
extracellular	  microbes	  but	  also	  harmful	  to	  host	  tissues	  if	  left	  unchecked.	  In	  fact,	  although	  this	  response	  
typically	  leads	  to	  the	  elimination	  of	  M.	  smegmatis,	  this	  extremely	  potent	  extracellular	  respiratory	  burst	  
caused	  by	  M.	  smegmatis	  could	  further	  explain	  its	  role	  in	  the	  rare	  acute	  and	  chronic	  inflammation	  and	  
tissue	  damage	  in	  soft	  tissue,	  wounds	  and	  the	  pleuropulmonary	  area.	  
CYTOKINE	  RELEASE	  
	  
Fig.	  8	  Extracellular	  oxidants	  
production.	  Human	  neutrophils	  
(4x106	  cells/ml)	  were	  exposed	  to	  
or	  ferricytochrome	  c,	  in	  the	  
presence	  of	  human	  serum	  
opsonized	  M.	  smegmatis	  or	  S.	  
aureus	  at	  an	  MOI	  of	  6:1.	  
Superoxide	  release	  was	  measured	  
as	  the	  superoxide	  dismutase-­‐
inhibitable	  reduction	  of	  
ferricytochrome	  c.	  Data	  are	  
expressed	  as	  mean	  ±	  SEM	  in	  
nmol/4x106	  cells	  of	  superoxide	  
release,	  *P<0.05	  compared	  to	  all	  
the	  experimental	  conditions.	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M.	  smegmatis	  reduced	  basal	  reserves	  of	  IL-­‐12	  without	  involvement	  by	  PILAM	  	  
	   	  
Fig.9	  IL-­‐12	  production	  and	  release.	  Human	  neutrophils	  (4x106	  cells/ml)	  were	  unstimulated	  (Basal),	  or	  stimulated	  with	  
Lipopolysaccharide	  (LPS,	  1	  μg/ml)	  +	  Interferon-­‐γ	  (IFN-­‐g,	  50ng/ml),	  or	  pre-­‐treated	  with	  non-­‐opsonized	  (Non-­‐op	  M.	  
smegmatis),	  serum	  opsonized	  (Op)	  M.	  smegmatis	  (MOI	  6:1,	  30	  min)(A)	  or	  20	  μg/mL	  of	  PILAM	  followed	  by	  LPS	  +	  IFN-­‐g	  
stimulation	  (B).	  Supernatants	  and	  cell	  lysates	  were	  collected	  after	  24	  h	  stimulation	  and	  IL-­‐12	  levels	  measured	  by	  ELISA.	  Data	  
are	  expressed	  as	  mean	  ±	  SEM	  of	  IL-­‐12	  levels	  (pg/ml),	  *	  p<0.05	  compared	  to	  lysate	  of	  non-­‐op	  and	  op-­‐M.	  smegmatis.	  	  
	  
	   Neutrophils	  are	  an	  important	  source	  of	  IL-­‐12	  because	  they	  store	  and	  produce	  new	  IL-­‐12	  when	  
they	  accumulate	  at	  sites	  of	  infection.	  The	  cytokine	  IL-­‐12	  is	  known	  to	  activate	  and	  differentiate	  T	  cells	  into	  
TH1	  cells,	  which	  release	  IFN-­‐γ,	  an	  activator	  for	  bacterial	  killing	  in	  macrophages.	  Therefore,	  the	  TH1	  
response	  is	  typically	  associated	  with	  the	  clearing	  of	  intracellular	  pathogens	  like	  mycobacteria.	  However,	  
when	  subjected	  to	  both	  opsonized	  and	  non-­‐opsonized	  M.	  smegmatis	  alone,	  the	  neutrophils’	  intracellular	  
IL-­‐12	  supply	  was	  significantly	  reduced	  when	  compared	  to	  untreated	  cells,	  and	  there	  was	  no	  release	  of	  the	  
cytokine	  (Fig.	  9A).	  M.	  smegmatis	  reduction	  of	  IL-­‐12	  levels	  within	  the	  cell	  provides	  a	  mechanism	  for	  long-­‐
term	  survival	  of	  the	  bacterium.	  If	  IL-­‐12	  is	  not	  secreted,	  then	  T	  cells	  and	  macrophages	  will	  remain	  
inactivated,	  allowing	  for	  increased	  bacterial	  proliferation	  and	  a	  higher	  probability	  of	  a	  chronic	  infection.	  	  
LPS	  and	  IFN-­‐γ-­‐activated	  neutrophils	  simulate	  the	  conditions	  of	  an	  ongoing	  inflammation,	  and	  after	  
neutrophils	  were	  stimulated	  with	  these	  agonists,	  neither	  opsonized	  nor	  non-­‐opsonized	  M.	  smegmatis	  was	  
able	  to	  make	  a	  difference	  in	  IL-­‐12	  extracellular	  release	  when	  compared	  to	  LPS	  and	  IFN-­‐γ	  stimulation	  
alone.	  Thus,	  M.	  smegmatis	  is	  independently	  capable	  of	  delaying	  the	  onset	  of	  IL-­‐12	  derived	  inflammatory	  
responses,	  but	  once	  inflammation	  is	  ongoing,	  it	  has	  little	  effect	  on	  the	  neutrophil	  IL-­‐12	  response.	  	  
Parenthetically,	  the	  LAM	  subunit	  of	  mycobacteria	  is	  a	  known	  potent	  inducer	  of	  IL-­‐12	  release	  in	  
macrophages	  (17),	  but	  a	  study	  between	  neutrophils	  and	  the	  phosphoinositol-­‐capped	  version	  of	  LAM	  has	  
never	  been	  performed.	  Despite	  the	  decreasing	  trend	  seen	  with	  the	  addition	  of	  20	  μg/mL	  of	  PILAM,	  it	  was	  
not	  statistically	  significant,	  indicating	  that	  PILAM	  has	  no	  effect	  on	  neutrophil	  release	  of	  IL-­‐12	  (Fig.	  9B).	  
This	  suggests	  that	  PILAM	  is	  not	  involved	  in	  IL-­‐12	  extracellular	  release.	  Although,	  this	  could	  be	  the	  case,	  it	  
B.	  A.	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would	  be	  worthwhile	  to	  repeat	  this	  experiment	  and	  obtain	  more	  than	  4	  independent	  experiments	  as	  well	  
to	  test	  with	  higher	  concentration	  of	  PILAM	  (40	  μg/mL)	  to	  further	  confirm	  these	  results.	  In	  addition	  to	  
this,	  it	  would	  be	  interesting	  to	  collect	  the	  lysates	  as	  well	  as	  the	  supernatants,	  as	  was	  done	  with	  M.	  
smegmatis,	  to	  determine	  if	  PILAM	  plays	  a	  part	  in	  the	  effect	  seen	  with	  the	  whole	  bacterium.	  	  
BACTERIAL	  KILLING	  
Neutrophils	  may	  or	  may	  not	  kill	  M.	  smegmatis	  at	  30	  minutes	  post-­‐infection	  
	  	  	  	  	  	  	  	  	  	  	  A.	  Live	  M.	  s.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  B.	  Heat-­‐killed	  M.	  s.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  C.	  UV-­‐killed	  M.s.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  D.	  Untreated	  PMN	  	  	  	  
	  	   	  
Opsonized	  M.	  smegmatis	  
E.	  Experiment	  1	  	   	   	   	   	   	   F.	  Experiment	  2	  
	  
Fig.8	  Bacterial	  viability	  Assay.	  Viable	  M.	  smegmatis	  (A),	  Heat-­‐killed	  M.	  smegmatis	  (B),	  UV-­‐killed	  M.	  smegmatis	  (C)	  were	  treated	  
with	  the	  combination	  of	  dyes,	  30	  μM	  PI	  and	  2	  μM	  SYTO	  9	  to	  use	  as	  controls.	  Then,	  neutrophils	  (2x106cell/ml)	  were	  
unstimulated	  (UT)	  (D),	  or	  stimulated	  with	  opsonized	  M.	  smegmatis	  (Ms;	  MOI	  6:1	  (E,	  F),	  in	  the	  presence	  of	  the	  PI	  and	  SYTO9.	  
Two	  independent	  experiments	  showed	  that	  after	  30	  minutes,	  intracellular	  bacteria	  were	  either	  live	  (E)	  or	  unviable	  (F).	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Finally,	  an	  assay	  measuring	  bacterial	  viability	  was	  customized	  to	  answer	  the	  question	  of	  how	  quickly	  
neutrophils	  kill	  M.	  smegmatis.	  This	  assay	  is	  still	  under	  development,	  which	  is	  why	  there	  are	  no	  definite	  
conclusions	  for	  this	  set	  of	  experiments;	  however,	  the	  troubleshooting	  of	  the	  assay	  has	  proven	  to	  be	  a	  
valuable	  source	  of	  learning	  and	  growth	  as	  a	  scientist.	  	  
At	  first,	  independent	  UV-­‐killed	  and	  live	  bacteria	  conditions	  were	  used	  as	  controls;	  the	  nonviable,	  
UV-­‐killed	  bacteria	  would	  stain	  red	  and	  live	  bacteria	  would	  stain	  green.	  However,	  the	  UV-­‐killed	  bacteria,	  
which	  should	  have	  stained	  95%	  red,	  were	  staining	  a	  mix	  of	  red	  and	  green	  (Fig	  8	  C).	  This	  was	  due	  to	  the	  
fact	  that	  UV	  exposure	  makes	  cells	  inviable	  by	  disrupting	  their	  DNA,	  whereas	  PI,	  the	  dye	  that	  labels	  the	  
dead	  bacteria,	  requires	  a	  disrupted	  membrane	  to	  enter	  the	  cell.	  As	  an	  alternative,	  heat	  was	  used	  for	  
membrane	  disruption	  and	  killing	  of	  M.	  smegmatis,	  which	  resulted	  in	  nonviable	  bacteria	  staining	  red	  and	  
the	  live,	  viable	  bacteria	  staining	  a	  district	  green	  (Fig.	  8	  A,	  B).	  	  The	  bacteria	  alone	  conditions	  were	  used	  to	  
set	  the	  laser	  levels	  for	  optimum	  bacterial	  visualization	  inside	  neutrophils.	  	  
The	  first	  experiment	  was	  a	  30-­‐minute	  challenge	  that	  displayed	  an	  overwhelmingly	  green	  bacterial	  
population	  indicative	  of	  100%	  bacterial	  survival	  inside	  neutrophils	  (Fig	  7	  E).	  This	  finding	  was	  surprising	  
given	  that	  our	  data	  showed	  that	  the	  presence	  of	  M.	  smegmatis	  incites	  a	  robust	  intracellular	  respiratory	  
burst	  at	  30	  minutes.	  Contrastingly,	  when	  an	  identical	  experiment	  was	  performed	  at	  a	  later	  date,	  the	  
intracellular	  bacterial	  population	  was	  an	  overpoweringly	  red	  color	  (Fig.	  8	  F).	  In	  this	  second	  experiment,	  
the	  neutrophils	  were	  able	  to	  kill	  almost	  100%	  of	  the	  bacteria	  internalized,	  yielding	  opposite	  results	  from	  
the	  previous	  experiment.	  There	  are	  several	  possibilities	  for	  the	  discrepancy	  of	  results.	  First	  of	  all,	  the	  
probability	  of	  a	  technical	  error	  cannot	  be	  discounted	  because	  this	  is	  a	  developing	  technique.	  If	  the	  laser	  
levels	  are	  not	  at	  the	  ideal	  setting	  or	  if	  the	  focus	  is	  unadjusted,	  the	  bacteria	  may	  not	  be	  visualized.	  An	  
alternative	  hypothesis	  to	  explain	  the	  results	  is	  based	  on	  the	  observation	  that	  in	  the	  all-­‐dead	  experiment,	  
the	  Syto9	  dyes	  stained	  very	  lightly,	  giving	  rise	  to	  the	  chance	  that	  the	  bacterial	  cells	  looked	  as	  if	  they	  were	  
all	  stained	  red	  when	  some	  may	  have	  actually	  been	  alive.	  The	  goal	  is	  to	  perform	  multiple	  experiments	  in	  
the	  future	  to	  standardize	  the	  data,	  but	  to	  further	  confirm	  the	  ability	  of	  neutrophils	  to	  kill	  M.	  smegmatis	  
another	  bacteria	  survival	  method	  will	  be	  used.	  	  Neutrophils	  will	  be	  challenged	  with	  opsonized	  bacteria,	  
and	  after	  the	  30	  min	  incubation,	  extracellular	  bacteria	  will	  be	  removed	  by	  antibiotic	  treatment,	  following	  
which	  cells	  will	  be	  lysed	  and	  the	  lysate	  used	  to	  streak	  a	  plate,	  after	  2-­‐3	  days,	  the	  bacterial	  colony-­‐forming	  
units	  (CFU)	  will	  be	  counted	  and	  compared	  to	  bacteria	  alone	  condition.	  If	  no	  colonies	  arise,	  it	  will	  indicate	  
that	  the	  bacteria	  were	  effectively	  killed	  by	  the	  neutrophils	  after	  30	  min	  incubation.	  	  
If	  later	  experiments	  and	  colony	  formation	  confirm	  that	  neutrophils	  do	  not	  kill	  M.	  smegmatis	  within	  
the	  first	  30	  minutes	  after	  infection,	  a	  previous	  study	  with	  M.	  smegmatis	  and	  neutrophils	  could	  give	  a	  
possible	  explanation	  for	  this	  phenomenon.	  	  While	  using	  an	  MOI	  of	  50,	  a	  group	  of	  researchers	  from	  France	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found	  that	  non-­‐opsonized,	  un-­‐clumped	  M.	  smegmatis	  impedes	  the	  fusion	  of	  azurophilic	  granules	  with	  the	  
phagosome	  (3).	  They	  concluded	  that	  mycobacteria	  do	  not	  actively	  control	  this	  response,	  and	  the	  effect	  
was	  mediated	  through	  receptors	  that	  despite	  triggering	  phagocytosis,	  do	  not	  initiate	  the	  intracellular	  
signals	  for	  fusion	  of	  the	  azurophil	  granules	  (3).	  Nonetheless,	  in	  order	  to	  mount	  the	  most	  efficient	  attack,	  it	  
could	  be	  necessary	  to	  combine	  intracellular	  oxidative	  burst	  and	  granule	  proteins	  in	  the	  phagosome.	  If	  the	  
granule	  containing	  the	  most	  microbicidal	  contents	  is	  blocked	  from	  fusing	  with	  the	  phagosome,	  the	  ROS	  in	  
the	  phagosome	  may	  take	  longer	  to	  kill	  the	  bacteria,	  as	  was	  shown	  in	  a	  prior	  study	  that	  compared	  
azurophilic	  versus	  specific	  granule	  contents’	  killing	  efficiency	  (33).	  In	  fact,	  azurophil	  granules	  are	  so	  
effective	  at	  microbial	  killing	  that	  when	  they	  were	  added	  to	  macrophages	  with	  phagocytized	  
mycobacteria,	  85%	  of	  intracellular	  M.	  smegmatis	  were	  killed	  within	  6	  hours	  post	  infection	  (33).	  
Therefore,	  by	  avoiding	  primary	  granule	  merging	  with	  the	  phagosome,	  M.	  smegmatis	  is	  able	  to	  prolong	  its	  
survival	  and	  proliferation	  time	  intracellularly.	  	  
However,	  it	  was	  also	  found	  that	  opsonizing	  the	  bacteria	  with	  IgG-­‐containing	  immunoserum	  could	  
restore	  the	  phagosome-­‐azurophil	  fusion	  ability	  (3).	  The	  recognition	  of	  this	  antibody	  could	  lead	  to	  the	  
special	  uptake	  of	  the	  bacterium	  through	  a	  different	  set	  of	  receptors.	  Subsequently,	  the	  phagocytosis	  by	  
these	  new	  receptors	  would	  activate	  the	  pathway	  that	  is	  most	  effective	  at	  clearing	  microbes	  by	  combining	  
ROS	  production	  and	  granule	  fusion	  with	  the	  phagosome.	  In	  our	  study,	  	  M.	  smegmatis	  	  was	  opsonized	  in	  
pooled	  human	  serum	  which	  resulted	  in	  opsonization	  by	  fixing	  complement	  but	  not	  immunoglobulins.	  If	  
the	  optimal	  way	  of	  eliminating	  intracellular	  M.	  smegmatis	  is	  through	  the	  pooled	  efforts	  of	  oxidative	  
species	  and	  granule	  proteins,	  the	  effect	  caused	  by	  the	  lack	  of	  IgG	  serum	  opsonization	  could	  be	  one	  way	  to	  
explain	  the	  majority	  of	  live	  bacteria.	  However,	  due	  to	  the	  rarity	  of	  M.	  smegmatis	  infections,	  it	  seems	  
unlikely	  that	  this	  mechanism	  could	  ward	  off	  neutrophil	  defenses	  for	  a	  prolonged	  period	  of	  time.	  	  	  
Conclusions	  &	  Future	  Directions	  
	  
It	  had	  been	  previously	  shown	  that	  M.	  smegmatis	  has	  the	  ability	  to	  modulate	  some	  responses	  in	  
professional	  phagocytic	  cells	  of	  the	  innate	  immune	  system	  like	  macrophages	  and	  neutrophils	  (3).	  
However,	  the	  mechanism	  for	  this	  modulation	  is	  unknown	  and	  many	  of	  the	  neutrophil	  bactericidal	  
functions	  against	  mycobacteria	  are	  still	  understudied.	  The	  goal	  of	  this	  thesis	  was	  to	  make	  a	  
comprehensive,	  comparative	  analysis	  between	  neutrophils	  and	  different	  types	  of	  M.	  smegmatis	  
treatments	  (opsonized,	  non-­‐opsonized)	  or	  the	  PILAM	  glycolipid	  that	  is	  typically	  associated	  with	  
mycobacterial	  virulence	  and	  immune	  system	  manipulation.	  Specifically,	  degranulation,	  intra	  and	  
extracellular	  ROS	  production,	  and	  cytokine	  release	  were	  examined	  because	  mycobacteria	  has	  been	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known	  to	  proliferate	  within	  leukocytes	  by	  inhibiting	  the	  fusion	  of	  the	  phagosome	  and	  lysosomes,	  
decreasing	  the	  production	  of	  ROS	  and	  interfering	  with	  the	  overall	  activation	  of	  the	  immune	  cells	  (33).	  	  
Our	  data	  showed	  that	  either	  treatment	  of	  M.	  smegmatis	  or	  PILAM	  alone	  was	  able	  to	  induce	  only	  
gelatinase	  granule	  exocytosis	  but	  no	  induction	  or	  reduction	  of	  the	  other	  three	  granule	  subtype	  was	  
observed.	  This	  is	  highly	  significant	  because	  there	  has	  been	  data	  to	  propose	  that	  neutrophils	  kill	  
mycobacteria	  through	  oxidation-­‐independent	  methods	  (34).	  Gelatinase	  granules	  mainly	  contain	  matrix	  
metalloproteases	  which	  when	  release	  to	  the	  extracellular	  space	  will	  induce	  tissue	  damage.	  	  The	  ability	  of	  
M.	  smegmatis	  to	  induce	  release	  of	  gelatinase	  granule	  might	  contribute	  to	  tissue	  damage	  seen	  with	  some	  
M.	  smegmatis	  infections.	  	  
A	  different	  story	  was	  discovered	  when	  neutrophils	  were	  pre-­‐treated	  with	  M.	  smegmatis,	  followed	  
by	  activation	  by	  fMLF.	  	  Pre-­‐treatment	  with	  opsonized	  M.	  smegmatis	  resulted	  in	  a	  robust	  increase	  of	  fMLF-­‐
stimulated	  secretory	  vesicle	  exocytosis,	  which	  decline	  with	  longer	  bacteria	  incubation	  times.	  	  These	  data	  
suggest	  that	  opsonized	  M.	  smegmatis	  may	  act	  as	  a	  priming	  agent.	  The	  decrease	  on	  secretory	  vesicle	  
exocytosis	  observed	  with	  longer	  bacteria	  incubations	  time	  could	  be	  due	  to	  stimulation	  of	  endocytic	  
events	  which	  result	  in	  downregulation	  on	  the	  expression	  of	  the	  fMLF	  receptor.	  	  Pre-­‐treatment	  of	  
neutrophils	  with	  either	  opsonized	  or	  non-­‐opsonized	  M.	  smegmatis	  resulted	  in	  a	  modest	  increase	  of	  fMLF-­‐
stimulated	  specific	  granule	  release.	  However,	  pre-­‐treatment	  with	  non-­‐opsonized	  M.	  smegmatis	  
significantly	  induced	  fMLF-­‐stimulated	  gelatinase	  and	  azurophil	  granule	  release.	  This	  confirmed	  
preceding	  findings	  that	  M.	  smegmatis	  is	  unable	  to	  independently	  mobilize	  the	  most	  bactericidal	  azurophil	  
and	  specific	  granules	  independently,	  but	  that	  it	  is	  able	  to	  amplify	  the	  response	  of	  neutrophils	  when	  other	  
infectious	  agents	  are	  present	  (8).	  Neutrophil	  priming	  results	  in	  a	  more	  severe	  response	  against	  
subsequently	  encountered	  microbes.	  In	  a	  pro-­‐inflammatory	  environment	  that	  simulates	  multi-­‐bacterial	  
conditions,	  the	  extracellular	  release	  of	  metalloproteases	  and	  myeloperoxidase	  from	  neutrophil	  granules	  
could	  contribute	  to	  the	  host	  tissue	  destruction	  associated	  with	  the	  rare	  chronic	  inflammations	  caused	  by	  
M.	  smegmatis.	  	  
Similarly,	  UV-­‐killed	  bacteria	  followed	  the	  same	  trend,	  suggesting	  that	  M.	  smegmatis	  has	  no	  active	  
control	  on	  the	  exocytosis	  of	  the	  microbicidal	  proteins,	  but	  that	  it	  is	  mediated	  through	  the	  signaling	  
pathways	  triggered	  by	  bacterial	  cell	  wall	  components.	  Consequently,	  PILAM	  was	  tested	  and	  found	  to	  
inhibit	  fMLF-­‐stimulated	  azurophil	  granule	  release.	  This	  finding	  suggests	  a	  mechanism	  by	  which	  
mycobacteria	  could	  avoid	  killing	  by	  the	  azurophil	  granule,	  although	  other	  cell	  membrane	  proteins	  may	  
overpower	  this	  effect	  since	  the	  opposite	  effect	  was	  seen	  with	  M.	  smegmatis.	  It	  would	  be	  interesting	  to	  test	  
other	  infamous	  proteins	  from	  the	  mycobacterial	  cell	  membrane	  to	  determine	  the	  cause	  of	  the	  effects	  seen	  
with	  the	  entire	  bacterium.	  Likewise,	  using	  UV-­‐killed	  M.	  smegmatis	  against	  all	  the	  granule	  types	  could	  also	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yield	  interesting	  results	  regarding	  the	  level	  of	  active	  modulation	  of	  these	  immune	  responses	  by	  M.	  
smegmatis.	  Another	  lead	  to	  follow	  in	  the	  study	  of	  these	  interactions	  is	  to	  see	  the	  amount	  of	  degranulation	  
into	  phagosomes	  when	  bacteria	  are	  internalized	  by	  neutrophils,	  which	  was	  not	  studied	  here.	  	  
The	  second	  major	  weapon	  in	  neutrophils’	  bactericidal	  arsenal	  is	  the	  production	  and	  release	  of	  
reactive	  oxidative	  species	  into	  the	  extracellular	  space	  or	  into	  bacteria-­‐containing	  phagosomes	  in	  the	  
cytoplasm.	  Extracellularly,	  opsonized	  M.	  smegmatis	  was	  capable	  of	  inciting	  a	  time-­‐dependent,	  extremely	  
robust	  oxidant	  production	  at	  60	  minutes,	  further	  even	  than	  the	  already	  potent	  inducer	  of	  ROS,	  S.	  aureus.	  
This	  implicates	  M.	  smegmatis	  even	  more	  as	  a	  modulator	  of	  innate	  immune	  responses	  because	  this	  
mechanism	  is	  likely	  associated	  with	  its	  killing,	  but	  in	  the	  are	  cases	  of	  infection,	  this	  response	  could	  
simultaneously	  harm	  host	  tissues.	  The	  result	  that	  opsonized	  M.	  smegmatis	  increases	  extracellular	  oxidant	  
production	  contradicts	  one	  previous	  study	  that	  found	  that	  at	  an	  MOI	  of	  50,	  neither	  opsonized	  nor	  
unopsonized	  bacteria	  were	  qualified	  to	  augment	  superoxide	  production	  (8).	  However,	  compared	  to	  the	  
MOI	  of	  6	  utilized	  in	  this	  thesis,	  the	  discrepancy	  in	  responses	  could	  be	  due	  to	  the	  extremely	  high	  
multiplicity	  of	  infection	  of	  the	  prior	  study.	  When	  neutrophils	  are	  exposed	  to	  such	  a	  high	  amount	  of	  
bacteria,	  different	  pathways	  and	  neutrophil	  functions	  like	  apoptosis	  could	  be	  initiated	  instead,	  thus	  
yielding	  the	  low	  oxidative	  response.	  	  
Similarly,	  in	  a	  time-­‐dependent	  fashion,	  opsonized	  M.	  smegmatis	  increased	  intracellular	  oxidant	  
production,	  more	  so	  than	  non-­‐opsonized	  M.	  smegmatis	  and	  both	  opsonized	  and	  non-­‐opsonized	  S.	  aureus.	  
When	  compared	  to	  the	  non-­‐opsonized	  M.	  smegmatis	  and	  S.	  aureus,	  this	  finding	  emphasized	  that	  the	  
uptake	  method	  by	  the	  neutrophil	  influences	  the	  fate	  of	  the	  microbe.	  Opsonization	  leads	  to	  recognition	  
and	  phagocytosis	  through	  the	  complement	  and/or	  FcγR	  receptor,	  which	  activates	  a	  different	  pathway,	  
leading	  to	  a	  more	  exaggerated	  oxidant	  production.	  	  The	  difference	  between	  the	  opsonized	  M.	  smegmatis	  
and	  S.	  aureus	  may	  be	  due	  to	  PILAM’s	  influence.	  Not	  only	  was	  PILAM	  able	  to	  significantly	  induce	  
intracellular	  ROS,	  but	  also,	  it	  was	  able	  to	  prime	  the	  intracellular	  response	  of	  S.	  aureus-­‐	  induced	  ROS.	  
However,	  despite	  the	  amplified	  intracellular	  oxidant	  response	  in	  regards	  to	  M.	  smegmatis,	  it	  was	  
unknown	  whether	  it	  occurred	  at	  the	  phagosome	  where	  pathogenic	  mycobacteria	  are	  known	  to	  
proliferate.	  Additionally,	  other	  sources	  have	  proposed	  that	  M.	  smegmatis	  is	  among	  the	  ranks	  of	  
mycobacteria	  that	  are	  able	  to	  delay	  phagosome	  maturation	  and	  acidification	  by	  blocking	  the	  recruitment	  
of	  lysosomes	  to	  the	  vesicle	  in	  macrophages	  (35,	  36).	  Nonetheless,	  images	  taken	  using	  a	  confocal	  
microscope	  confirm	  that	  the	  intracellular	  ROS	  is	  taking	  place	  at	  the	  phagosome,	  where	  the	  bacteria	  are	  
localized.	  What	  remains	  unknown	  is	  whether	  or	  not	  there	  is	  phagosome	  maturation	  involving	  the	  
granules,	  which	  points	  to	  a	  direction	  this	  study	  may	  explore	  in	  the	  future.	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Another	  major	  function	  of	  neutrophils	  explored	  in	  this	  study	  was	  the	  release	  of	  cytokines	  that	  
mediate	  the	  transition	  between	  the	  innate	  to	  adaptive	  immunity,	  notably	  IL-­‐12.	  Neutrophils	  have	  recently	  
become	  recognized	  as	  an	  important	  source	  for	  this	  molecule,	  which	  leads	  to	  favorable	  responses	  against	  
intracellular	  pathogens	  during	  the	  initial	  stages	  on	  infection.	  	  Neutrophil	  challenge	  with	  both	  opsonized	  
and	  non-­‐opsonized	  	  M.	  smegmatis	  led	  to	  the	  decrease	  in	  intracellular	  storage	  of	  IL-­‐12,	  as	  compared	  to	  the	  
untreated	  cells.	  This	  interference	  in	  neutrophils’	  IL-­‐12	  production	  and	  storage	  could	  sway	  immune	  
responses,	  allowing	  M.	  smegmatis	  or	  other	  bacteria	  present	  to	  continue	  surviving	  and	  proliferating.	  	  
Lastly,	  a	  technique	  for	  determining	  M.	  smegmatis’	  viability	  post-­‐infection	  is	  being	  developed,	  
although	  definitive	  results	  have	  not	  been	  acquired.	  The	  two	  experiments	  performed	  had	  opposite	  results,	  
one	  displaying	  minimal	  microbial	  killing	  after	  a	  30	  minute	  challenge,	  and	  the	  other	  showing	  almost	  
complete	  annihilation	  of	  the	  internalized	  bacteria.	  For	  the	  presented	  studies	  primary	  human	  neutrophils	  
from	  healthy	  donors	  are	  used	  and	  there	  is	  variation	  between	  individuals	  which	  could	  explain	  the	  
different	  results.	  	  Even	  though	  the	  experiment	  requires	  more	  attempts	  in	  order	  to	  standardize	  the	  data,	  
previous	  studies	  with	  M.	  smegmatis	  give	  plausible	  explanations	  for	  either	  outcome.	  It	  has	  been	  
propositioned	  that	  M.	  smegmatis	  has	  the	  capability	  of	  blocking	  the	  fusion	  of	  the	  phagosome	  with	  
azurophil	  granules,	  which	  could	  delay	  the	  killing	  of	  the	  microbe	  (3).	  	  Likewise,	  M.	  smegmatis	  contains	  an	  
oxidant	  scavenger	  protein,	  SOD,	  which	  could	  alleviate	  the	  oxidative	  stress	  from	  the	  respiratory	  burst.	  	  
These	  mechanisms	  could	  be	  collaborating	  to	  keep	  the	  bacteria	  alive	  for	  as	  long	  as	  possible.	  In	  addition	  to	  
visual	  inspection	  via	  confocal	  microscopy,	  future	  studies	  will	  utilize	  another	  technique	  to	  evaluate	  
bacteria	  viability	  by	  counting	  colony-­‐forming	  units	  	  
In	  conclusion,	  neutrophils’	  responses	  to	  M.	  smegmatis	  indicate	  that	  this	  non-­‐pathogenic,	  
environmental	  mycobacterium	  can	  promote	  inflammation,	  tissue	  damage,	  and	  manipulate	  the	  Th1	  
response	  by	  controlling	  production	  of	  IL-­‐12.	  Also,	  our	  data	  suggests	  that	  PILAM	  is	  involved	  in	  the	  M.	  
smegmatis	  modulation	  of	  intracellular	  ROS,	  gelatinase	  granule	  exocytosis	  and	  IL-­‐12	  release.	  Therefore,	  
the	  interaction	  between	  these	  avirulent	  bacteria	  and	  human	  neutrophils	  is	  more	  complex	  and	  interesting	  
than	  ever	  before.	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